{"text": "Following six month treatment , they reported no difference in antibiotic usage although lung function was maintained in the colistin group and declined significantly in patients receiving placebo .", "label": "", "metadata": {}, "score": "48.24966"}
{"text": "All patients received antimicrobial therapy for presumptive osteomyelitis .All patients underwent serial surgical debridement of wounds until there was no further nonviable or grossly infected tissue present .", "label": "", "metadata": {}, "score": "49.901237"}
{"text": "Four of them were cared for by the transplant team and the fifth was in a medical ward in a separate building .One of the patients died .", "label": "", "metadata": {}, "score": "51.816444"}
{"text": "In addition , there is still a lack of PK / PD information to optimize colistin doses in humans , especially those who are hospitalized in the ICUs .", "label": "", "metadata": {}, "score": "53.19818"}
{"text": "In the present study , patients who presented KPRC infection in the ICU had increased mortality , required longer duration of mechanical ventilation and sedation , and stayed for a longer period in the ICU compared to patients who had not acquired an infection in the ICU .", "label": "", "metadata": {}, "score": "53.518448"}
{"text": "No difference in overall bacterial killing was found .However , the 8-hourly regimens appeared most effective at minimizing the onset of resistance .", "label": "", "metadata": {}, "score": "55.43493"}
{"text": "A significant reduction in the consumption of oral antibiotics ( from 28 to 7 days / year ) and number of hospitalizations ( from 4 to 1/year ) were observed .", "label": "", "metadata": {}, "score": "55.767673"}
{"text": "The hardware was retained in all 4 of these patients .Two patients had proven osteomyelitis as determined by positive bone culture or characteristic bone histology .", "label": "", "metadata": {}, "score": "55.988968"}
{"text": "The colistin was safe and effective with treatment being associated with significant improvement in spirometry .There were no adverse effect on renal function and no neurotoxicity .", "label": "", "metadata": {}, "score": "56.1297"}
{"text": "This subjects the patient to the risks inherent to long - term intravenous access and may place the patient at an increased risk of adverse medication effects .", "label": "", "metadata": {}, "score": "56.80436"}
{"text": "No other patient experienced an adverse effect that was attributable to minocycline therapy .The average length of follow - up for these successfully treated cases was approximately 6 weeks ( range , 2 weeks-17 months ) .", "label": "", "metadata": {}, "score": "57.123306"}
{"text": "In each patient , two courses of conventional treatment were followed by two courses of quinolone treatment and then by other two courses of conventional treatment .", "label": "", "metadata": {}, "score": "57.235363"}
{"text": "He was transferred to the transplant intensive care unit , and on March 10 , his Klebsiella infection was discovered to have become colistin - resistant .", "label": "", "metadata": {}, "score": "57.27204"}
{"text": "In a patient undergoing continuous venovenous hemodiafiltration , conversion of CMS to colistin was rapid , and the terminal half - lives of CMS and colistin were 6.8 and 7.5 h , respectively [ 16 ] .", "label": "", "metadata": {}, "score": "57.351746"}
{"text": "The authors speculated that a loading colistin dose of 9 or 12 m. units along with a maintenance dose of 4.5 m. units administered every 12 h is necessary in critically ill patients [ 14 ] .", "label": "", "metadata": {}, "score": "57.459"}
{"text": "Hansen et al .[ 48 ] included 146 patients and used oral ciprofloxacin ( 25 - 50 mg / kg / d ) and inhalations of colistin ( 2 million units TID ) for 3 months .", "label": "", "metadata": {}, "score": "57.490463"}
{"text": "( 1.43 - 12.56 ) ) and for longer period ( days ) compared to patients who presented no documented infection ( Table 3 ) .", "label": "", "metadata": {}, "score": "57.805557"}
{"text": "With continuing treatment , only 9 % were found to be chronically infected over a six - month period , and on further follow - up , only a low level of resistance was found to anti - staphylococcal antibiotics [ 79 ] .", "label": "", "metadata": {}, "score": "58.0164"}
{"text": "In conclusion , our findings provide evidence that prior use of antibiotics , in particular , prolonged use of colistin , is an independent factor for KPRC infection .", "label": "", "metadata": {}, "score": "58.202446"}
{"text": "Moreover , we found that colistin was also associated with increased risk of KPRC infection and that the duration of colistin administration was an independent risk factor for KPRC infection .", "label": "", "metadata": {}, "score": "58.23282"}
{"text": "However , although the potential for a longer dosing interval may be an option in critically ill patients , some studies found that when the intervals of colistin doses increase , the prevalence of colistin resistance also increases .", "label": "", "metadata": {}, "score": "58.309082"}
{"text": "The mean duration of colistin administration was 17.9 days and the interquartile range was 10 - 22 days .Cure of infection occurred in 79.1 % of patients .", "label": "", "metadata": {}, "score": "59.287613"}
{"text": "Studies about the optimum duration of colistin administration and the implementation of Antimicrobial Stewardship Programs may improve antimicrobial use in Intensive Care Units in order to prevail growing antimicrobial resistance .", "label": "", "metadata": {}, "score": "59.87661"}
{"text": "Four patients had open bone fractures , and 4 patients had traumatic amputations of a limb .Fixation devices were used on all 4 patients with open fractures .", "label": "", "metadata": {}, "score": "59.9059"}
{"text": "All patients showed clinical improvement and resolution of their acute exacerbation with no significant difference between the two antibiotic regimens in terms of change in FEV1 , FVC , overnight oxygen saturations and clinical scores after 12 days of therapy .", "label": "", "metadata": {}, "score": "59.940907"}
{"text": "Additionally , little is known about the pharmacokinetics / dynamics of colistin [ 26 , 27 ] .Notably , colistin administration as the appropriate treatment - based on in vitro bacterial susceptibility to antibiotics - was not associated with improved survival in KPRC infection according to previous studies [ 20 ] .", "label": "", "metadata": {}, "score": "59.945564"}
{"text": "The second is how these unexpectedly resistant hospital infections complicate the course of an already - sick patient .The victims in this outbreak were in the hospital from six weeks , in the shortest course , to six months in the longest .", "label": "", "metadata": {}, "score": "60.148407"}
{"text": "Colistin was associated with a significantly better clinical symptom score , slower deterioration of pulmonary function ( significant for FVC ) and reduced inflammatory parameters ( Jensen et al , 1987 ) .", "label": "", "metadata": {}, "score": "60.53734"}
{"text": "Survivors compared to non - survivors had younger age ( Table 5 ) , received MV or sedation for shorter duration and underwent less frequently invasive procedures .", "label": "", "metadata": {}, "score": "60.797134"}
{"text": "Data come from in vitro experiments on a murine animal model [ 38 ] as well as in vivo .All treated patients experienced clinical and microbiological cure at 1-month follow - up , although four patients experienced a recurrence of their UTI [ 41 ] .", "label": "", "metadata": {}, "score": "61.30226"}
{"text": "These studies highlighted the importance of achieving adequate time - averaged exposure to colistin across the day [ 11 , 12 ] .These studies performed in animals will facilitate efforts to define in the near future the more rational design of CMS doses in humans , especially in the ICU setting .", "label": "", "metadata": {}, "score": "61.557693"}
{"text": "Only a few case reports in the literature deal with the intrathecal administration of colistin for the treatment of ventriculitis and shunt infections due to carbapenem resistant P. aeruginosa and A. baumannii [ 19 - 21 ] .", "label": "", "metadata": {}, "score": "61.667953"}
{"text": "His colistin - resistant infection was discovered just nine days later .The fourth patient , a 42-year - old man , also needed a liver transplant .", "label": "", "metadata": {}, "score": "62.066856"}
{"text": "A more recent study by Ledson et al reported their four year experience of intravenous colistin in an adult CF unit ( Ledson et al , 1998 ) .", "label": "", "metadata": {}, "score": "62.112576"}
{"text": "This enforces the importance of colistin dose optimization in critically ill patients .Although higher colistin doses seem to be beneficial , the lack of colistin pharmacokinetic - pharmacodynamic data results in difficulty for the optimization of daily colistin dose .", "label": "", "metadata": {}, "score": "62.13965"}
{"text": "Only those variables which were significantly associated with KPRC infection or mortality in the univariate analysis were entered in the stepwise logistic regression models .For KPRC infection , analysis was performed between two groups ( patients with KPRC and all other patients ) ; colistin duration , MV , invasive procedures were assessed as risk factors for KPRC infection .", "label": "", "metadata": {}, "score": "62.278713"}
{"text": "In addition , 3 of the patients did not receive concurrent therapy and still had successful outcomes .A more important limitation is that in most patients , coinfection with another pathogen was also present .", "label": "", "metadata": {}, "score": "62.388226"}
{"text": "Clinical Assessment .For survivors and nonsurvivors , several characteristics that might affect mortality were recorded : age , sex , severity of illness , comorbidities , invasive procedures , appropriate antibiotic treatment , total duration of mechanical ventilation ( MV ) and sedation , and KPRC infection .", "label": "", "metadata": {}, "score": "62.65156"}
{"text": "Following treatment , an increase in S. maltophilia was noted ( OR 3.97 , 95 % CI 2.27 to 6.94 ) with no differences between the two arms ( OR 0.89 , 95 % CI 0.44 to 1.78 ) .", "label": "", "metadata": {}, "score": "63.152836"}
{"text": "The CMS dose was 225 mg administered every 8 or 12 h for at least 2 days .The authors concluded that higher doses of CMS should be considered in critically ill patients [ 13 ] .", "label": "", "metadata": {}, "score": "63.457108"}
{"text": "Nature and duration of treatment for each infection were at physicians ' discretion .Infection control policy included isolation techniques in patients with MDR bacteria and continuous surveillance of nosocomial infections .", "label": "", "metadata": {}, "score": "63.633514"}
{"text": "Reported experience of adverse reactions did not include patients with CF and appears to be both reversible and dose dependent .Conway et al carried out a randomised study comparing the use of colistin ( 2 Mega units t.d.s . ) versus colistin in combination with a second anti - Pseudomonal antibiotic ( Conway et al , 1997 ) .", "label": "", "metadata": {}, "score": "63.782845"}
{"text": "A formal challenge with pre and post inhalation lung function should be undertaken before instituting therapy .All patients should be assessed for compliance with therapy and reviewed on a regular basis .", "label": "", "metadata": {}, "score": "63.890087"}
{"text": "Early clinical reports of severe toxicity with the use of colistin are likely to have occurred as a result of inappropriate patient selection , higher than recommended doses and inappropriate monitoring ( Li et al , 2005 ) .", "label": "", "metadata": {}, "score": "64.41243"}
{"text": "In a recently published study , 258 adult critically ill patients ( mean age 61 years ) received i.v .colistin for at least 72 hours for microbiologically documented MDR Gram - negative infections mainly due to A. baumannii ( 65.9 % ) and P. aeruginosa ( 26.4 % ) .", "label": "", "metadata": {}, "score": "64.58461"}
{"text": "Frederiksen et al .[47 ] included 91 participants and used oral ciprofloxacin ( 25 - 50 mg / kg / d ) and inhalations of colistin ( 1 million units BID ) for 3 weeks .", "label": "", "metadata": {}, "score": "64.9277"}
{"text": "Finally , the long term administration of aminoglycosides may also pose a risk of renal toxicity and close monitoring is needed to ensure that treatment does not result in significant nephrotoxicity .", "label": "", "metadata": {}, "score": "65.11123"}
{"text": "The optimal dose of colistin has not been determined in the ICU setting , because since there is a lack of relative clinical studies .In addition , there is lack of colistin 's PK / PD data in critically ill patients .", "label": "", "metadata": {}, "score": "65.310875"}
{"text": "View Article .Santamar\u00eda C , Mykietiuk A , Temporiti E , Stryjewski ME , Herrera F , Bonvehi P : Nephrotoxicity associated with the use of intravenous colistin .", "label": "", "metadata": {}, "score": "65.31497"}
{"text": "In fact , a recent phase 2 randomized controlled trial of patients with hospital - acquired pneumonia studied higher doses of tigecycline ( 150 mg loading followed by 75 mg every 12 hours , and 200 mg loading followed by 100 mg maintenance dose every 12 hours ) versus imipenem / cilastatin .", "label": "", "metadata": {}, "score": "65.39397"}
{"text": "A better understanding of colistin PK - PD properties is urgently needed to determine the optimal dosing regimen in colistin monotherapy or combination therapy for the effective management of life - threatening nosocomial infections due to MDR GNB in critically ill patients .", "label": "", "metadata": {}, "score": "65.44252"}
{"text": "They found that after three to 14 months therapy , there was a significant reduction in the number of positive cultures with three patients having repeatedly negative cultures ( Littlewood et al , 1985 ) .", "label": "", "metadata": {}, "score": "65.58585"}
{"text": "Longer hospitalisation may additionally predispose in greater risk for colonization with KPRC strains [ 32 , 33 ] through patient - to - patient transmission .", "label": "", "metadata": {}, "score": "66.025566"}
{"text": "A sixth patient was treated with minocycline after developing renal toxicity after 2 weeks of colistin therapy .The seventh patient received imipenem for 6 weeks but relapsed with imipenem - resistant MDR - ABC and was subsequently treated with minocycline .", "label": "", "metadata": {}, "score": "66.106155"}
{"text": "Hundred five patients were assigned to inhaled colistin / oral ciprofloxacin ( arm A ) and 118 were assigned to inhaled tobramycin / oral ciprofloxacin ( arm B ) .", "label": "", "metadata": {}, "score": "66.461975"}
{"text": "This exposure was significantly greater than prior exposure to intravenous or nebulised tobramycin in either group .Furthermore the dose of colistin used was only 1 mega unit twice a day which is half the standard dose used by many specialist units in the UK ; this may have reduced clinical effectiveness of the drug .", "label": "", "metadata": {}, "score": "66.65647"}
{"text": "Antibiotic therapy was associated with a statistically significant rise in blood urea and not creatinine at day 12 in both groups .While a significant number of adverse neurological events ( dizziness , numbness , tingling , incoordination , unsteadiness , muscle weakness ) were reported after direct questioning , only one patient described the symptoms of dizziness and muscle weakness as severe and withdrew from the study .", "label": "", "metadata": {}, "score": "66.688065"}
{"text": "In the present study , we aimed to identify clinical risk factors for the first episode of KPRC infection in ICU .Our findings suggest that KPRC infection was associated with the prior use of antibiotics , in particular carbapenems and most notably with colistin .", "label": "", "metadata": {}, "score": "66.69577"}
{"text": "The Role of Systemic Antibiotics .Oral Fluoroquinolones Compared to Placebo or Other Antibiotics .In the treatment group , patients reported a significant improvement in cough and PEF but not in the FEV1 and FVC .", "label": "", "metadata": {}, "score": "66.82097"}
{"text": "In a meta - analysis of trials using various antibiotics , Mukhopadhyay et al concluded that nebulised antibiotics significantly reduced the density of P. aeruginosa in the sputum and the frequency of respiratory exacerbations ( Mukhopadhyay et al , 1996 ) .", "label": "", "metadata": {}, "score": "66.98338"}
{"text": "In a prospective multicenter interventional trial of iv meropenem ( 120 mg / kg / day ) or iv ceftazidime ( 200 - 400 mg / kg / day ) , each administered together with iv tobramycin ( 9 - 12 mg / kg / day ) and 78 patients were included for suppression therapy of chronic P. aeruginosa colonization [ 72 ] .", "label": "", "metadata": {}, "score": "67.07879"}
{"text": "Results .A total of 280 patients were studied ( Figure 1 ) .KPRC was isolated at mean ( SE ) 13.1 ( 1.9 ) ICU days and non - MDR bacteria at 6.78 ( 1.756 ) ICU days .", "label": "", "metadata": {}, "score": "67.25181"}
{"text": "Yet , in another crossover design , the authors included 7 participants with mean age of 15.6 years and administered gentamicin ( 80 mg )TID for 3 months [ 65 ] .", "label": "", "metadata": {}, "score": "67.2787"}
{"text": "Alternative nebulised antibiotics such as TOBI are used as part of third line eradication therapy or if colistin is not tolerated .A Leeds audit ( unpublished ) found no significant difference between the various eradication regimens although there was a trend towards a higher success rate in those individuals who received two weeks IV antibiotics in combination with three months of nebulised colistin .", "label": "", "metadata": {}, "score": "67.33334"}
{"text": "The patient received tigecycline , and developed tigecycline resistance .Colistin continued to work , and the patient recovered .But now tigecycline resistance is out there , and may be circulating .", "label": "", "metadata": {}, "score": "67.502625"}
{"text": "[PubMed ] .Hodson ME , Gallagher CG , Govan JR .A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis .", "label": "", "metadata": {}, "score": "67.56093"}
{"text": "every 8 h. The fraction of CMS reaching the respiratory tract was 60 % of the initial dose .An interesting finding of this study was that colistin was undetected in lung tissue after intravenous infusion .", "label": "", "metadata": {}, "score": "67.75374"}
{"text": "We considered as immunocompromised any patient who was transplanted or received immunosuppressive agents , including corticosteroids .Tracheal aspirate or other type of cultures were quantitative except blood cultures .", "label": "", "metadata": {}, "score": "67.76402"}
{"text": "[ 22 ] examined recently colistin concentrations in serum and CSF samples in five critically ill patients who received CMS for CNS infections due to MDR GNB .", "label": "", "metadata": {}, "score": "67.78885"}
{"text": "In addition , no study has been performed to assess the colistin concentrations achieved in the pulmonary epithelial lining fluid , which is the target site for antibiotics , in the treatment of pneumonia .", "label": "", "metadata": {}, "score": "67.88815"}
{"text": "No clinical data exist on colistin dosing for patients receiving continuous renal replacement therapy .Based on the PK properties of colistin , the recommended dose of colistin in this group of patients is 2.5 mg / kg q 48 h. However , there are serious doubts about this recommendation .", "label": "", "metadata": {}, "score": "67.89748"}
{"text": "Minocycline therapy led to clinical cure for 7 of these patients .The remaining patient experienced adverse effects from minocycline requiring a change in therapy .", "label": "", "metadata": {}, "score": "67.94161"}
{"text": "At daily colistin doses of 9 m. units ( 3 m. units administered every 8 h ) , it would take 2 - 3 days before the steady - state concentration was achieved .", "label": "", "metadata": {}, "score": "68.103134"}
{"text": "It is our opinion that colistin as a bolus should not be given to patients without central venous access as in some it may induce significant phlebitis .", "label": "", "metadata": {}, "score": "68.10657"}
{"text": "[49 ] included 41 patients and used oral ciprofloxacin ( 30 mg / kg / d ) and inhalations of colistin ( 2 million units BID ) for 3 months .", "label": "", "metadata": {}, "score": "68.17014"}
{"text": "Ann Pharmacother .[PubMed ] .Cunningham S , Prasad A , Collyer L , et al .Bronchoconstriction following nebulised colistin in cystic fibrosis .", "label": "", "metadata": {}, "score": "68.1858"}
{"text": "Similar rates of nephrotoxicity are reported by other studies [ 24 - 26 ] .please , delete reference No 11 On the contrary , Koomanachai et al . and Kim et al . reported a colistin - induced nephrotoxicity in approximately 30 % of patients [ 27 , 28 ] .", "label": "", "metadata": {}, "score": "68.26529"}
{"text": "[PubMed ] .Dodd ME , Abbott J , Maddison J , et a l. Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis .", "label": "", "metadata": {}, "score": "68.327545"}
{"text": "Inappropriate empirical treatment was associated more frequently with KPRC infection ( Table 3 ) .Multivariate analysis revealed that colistin duration of administration was an independent risk factor for KPRC infection ( OR ( 95%CI ) .", "label": "", "metadata": {}, "score": "68.39388"}
{"text": "In an open prospective clinical trial , the clinical efficacy of the conventional aminoglycoside plus beta - lactam treatment was compared to that of monotherapy with oral quinolones in 26 adult patients [ 70 ] .", "label": "", "metadata": {}, "score": "68.39678"}
{"text": "The percentage of the uninfected patients which were colonized with bacteria in the study period was estimated up to 39.5 % ; the percentage of uninfected patients with KPRC colonization was up to 6.9 % .", "label": "", "metadata": {}, "score": "68.47587"}
{"text": "used two murine infection models to identify the most predictive PK / PD index of the antibacterial activity of colistin against P. aeruginosa and A. baumannii strains .", "label": "", "metadata": {}, "score": "68.48523"}
{"text": "The median time necessary to obtain CSF sterilization seems to be approximately 5 days .Toxicity probably or possibly related to the topical administration of colistin is noted in approximately 15 % of patients .", "label": "", "metadata": {}, "score": "68.51045"}
{"text": "As previously mentioned , Tumbarello and colleagues [ 23 ] found the triple - combination regimen of colistin , tigecycline , and meropenem to be associated with the highest odds of survival in their multicenter retrospective cohort study of 125 patients with KPC - producing K. pneumoniae bloodstream infections .", "label": "", "metadata": {}, "score": "68.55992"}
{"text": "Moreover , the application of MV includes procedures that interrupt the physiologic defence barriers and usually requires sedation , and thus it might favour the development of nosocomial infections [ 31 ] .", "label": "", "metadata": {}, "score": "68.7437"}
{"text": "For over a decade , colistin has been used in the UK as routine therapy for patients chronically infected with P. aeruginosa ( Hoiby et al , 2005 ) .", "label": "", "metadata": {}, "score": "69.04116"}
{"text": "Two placebo controlled trials looking at the effectiveness of long term nebulised colistin therapy for chronic P. aeruginosa infection have been undertaken to date .The first prospective double - blind placebo - controlled study compared nebulised colistin ( 1 mega unit b.d . ) with normal saline ( placebo ) in 40 patients ( age seven to 35 years ) over a three month period .", "label": "", "metadata": {}, "score": "69.12161"}
{"text": "Minocycline therapy resulted in clinical cure of the infection in 7 of the patients .The other patient was improving on minocycline , but developed eosinophilia and neutropenia attributable to the minocycline , which resolved after discontinuing the medication .", "label": "", "metadata": {}, "score": "69.41692"}
{"text": "The third patient changed the pattern , because he developed colistin - resistant Klebsiella even though he had never received the drug , making it likely that the resistant organism was passed to him from another patient by a health care worker or something in the hospital environment .", "label": "", "metadata": {}, "score": "69.50182"}
{"text": "If proven effective , their introduction will result in improvement in patient 's compliance and quality of life .References .Alothman GA , Ho B , Alsaadi MM , et al .", "label": "", "metadata": {}, "score": "69.61966"}
{"text": "Of note , colistin monotherapy was administered to less than half of the patients in this study .Most patients received combination therapy with a carbapenem or aminoglycoside in addition to colistin , although only eight Klebsiella pneumoniae isolates were susceptible to gentamicin and none of the isolates was susceptible to carbapenems [ 17 ] .", "label": "", "metadata": {}, "score": "69.65077"}
{"text": "Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis .Thorax 1997 ; 52:987 - 993 .[PubMed ] .Conway SP , Etherington C , Munday J , et al .", "label": "", "metadata": {}, "score": "69.698074"}
{"text": "Colistin monotherapy is not recommended for organisms with MICs to colistin of at least 4 mg / L [ 16 ] .For patients with underlying renal injury , the dosing interval was adjusted appropriately based on their renal clearance .", "label": "", "metadata": {}, "score": "69.7826"}
{"text": "Dosing recommendations for colistin - based products available for parenteral use in critically ill patients .These doses are based on normal renal function ; renal adjustment is indicated for creatinine clearance of less than 50 mL / minute [ 17 ] .", "label": "", "metadata": {}, "score": "69.78487"}
{"text": "[17 ] in patients with cystic fibrosis .In this multicenter study , a single dose of CMS ( 2 m. units ) was administered via inhalation to assess sputum , serum , and urine concentrations .", "label": "", "metadata": {}, "score": "69.79382"}
{"text": "Figure 3 : Over the 10 years studied the number of patients receiving nebulised colistin as maintenance treatment increased by 6.2 patients per year .The regular twice daily administration of a nebulised antibiotic has been an established treatment for chronic P. aeruginosa chest infection in CF between exacerbations since Hodson et al . published their paper in 1981 comparing nebulised gentamicin and carbenicillin with placebo in a double blind cross - over trial in 20 adult patients ( Hodson et al , 1981 ) .", "label": "", "metadata": {}, "score": "69.80524"}
{"text": "Because of this poor clearance , the recommended dose of colistin should be 2 mg / kg / day .During the past decade , inhaled colistin has been used for the treatment of nosocomial pneumonia or VAP due to MDR GNB , mostly P. aeruginosa and A. baumannii , to improve lung parenchyma penetration .", "label": "", "metadata": {}, "score": "69.9224"}
{"text": "The antimicrobial susceptibility profiles for each patient are listed in Table 2 .Six of the patients had carbapenem - resistant isolates at the beginning of therapy .", "label": "", "metadata": {}, "score": "69.964294"}
{"text": "administration to produce derivatives , including the active drug colistin .It is not absorbed from the gastrointestinal tract .Distribution of CMS to lung parenchyma , pleural cavity , pericardial fluids , and CSF is poor .", "label": "", "metadata": {}, "score": "69.97522"}
{"text": "Renal replacement therapy .The steady - state colistin serum concentrations have been measured in 14 septic patients with stable renal function in a general ICU after i.v .", "label": "", "metadata": {}, "score": "70.01367"}
{"text": "Adults -75,000 units / kg / day .( Maximum 6 MU per 24 hrs ) .The colistin should be diluted with 50 ml 0.9 % saline and infused over 30 minutes .", "label": "", "metadata": {}, "score": "70.07106"}
{"text": "Lu et al .[ 18 ] compared lung tissue deposition and antibacterial efficiency between nebulized and intravenous administration of colistin in piglets with pneumonia caused by P. aeruginosa .", "label": "", "metadata": {}, "score": "70.29766"}
{"text": "Twenty - five patients presented KPRC infection , 18 presented non - MDR bacterial infection , and 39 patients presented no infection .Compared to patients without documented infection or infected by non MDR bacteria , patients with KPRC infection had received more frequently or for longer duration antibiotics against Gram - negative bacteria ( carbapenems , colistin . )", "label": "", "metadata": {}, "score": "70.39215"}
{"text": "Last night ( Aug. 16 ) , the Journal of Antimicrobial Chemotherapy published an advance - access letter that describes a patient infected with E. coli that was carrying NDM-1 .", "label": "", "metadata": {}, "score": "70.44359"}
{"text": "Poudyal et al .[ 6 ] found initial rapid killing against K. pneumoniae strains even at the lowest colistin concentration .Similarly with the previous study dealing with the colistin pharmacodynamics against MDR A. baumannii , colistin exhibited no PAE at up to 64 \u00d7 MIC , regrowth in the majority of isolates at 4 h and hetero - resistance to colistin in MDR but colistin - susceptible K. pneumoniae strains .", "label": "", "metadata": {}, "score": "70.663666"}
{"text": "Recent data shows that the effects of chronicinfection are more severe in those who acquired it at an earlier age [ 56 ] .There are many protocols which utilize inhaled / nebulized or oral or intravenous ( i.v . ) antipseudomonal antibiotics for treatment of chronic infection .", "label": "", "metadata": {}, "score": "70.71175"}
{"text": "[ nothing new in this one ] .Perpati G , Pouliou E , Stefanatou E , et al .Long - term effect of inhaled colomycin on exercise capacity in adult patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "70.7797"}
{"text": "Introduction .The management of multidrug resistant ( MDR ) bacterial infections in the Intensive Care Unit ( ICU ) is a challenging issue for both physicians and infection control teams .", "label": "", "metadata": {}, "score": "70.81917"}
{"text": "Samples from only 10 and 5 patients remained negative 3 and 6 months after treatment , respectively .Only 5 children remained free from P. aeruginosa for a prolonged period from 14 to 32 months .", "label": "", "metadata": {}, "score": "70.828316"}
{"text": "He stayed in the hospital until he died in late May.Finally , the fifth patient - a 41-year - old woman with a traumatic brain injury - never went near the transplant unit .", "label": "", "metadata": {}, "score": "70.877045"}
{"text": "To our knowledge , the present study is the first prospective study which aimed to identify risk factors for KPRC infection in the ICU setting and may provide useful data in the implementation of effective infection control policies .", "label": "", "metadata": {}, "score": "70.94114"}
{"text": "The authors found reduced rate of respiratory events ( dyspnea and wheezing ) more with FTI than placebo and more with an 80/20 mg dose of FTI than 160/40 mg dose .", "label": "", "metadata": {}, "score": "70.95545"}
{"text": "Reports of resistance to colistin among KPC - producing K. pneumoniae strains [ 25 , 26 ] , though rare , are concerning , especially for combination treatment regimens where colistin is intended as the major active component .", "label": "", "metadata": {}, "score": "70.99832"}
{"text": "Treatment failure ( P. aeruginosa positive culture immediately after the end of treatment of first ever isolate ) was a strong risk factor for development of chronic infection after 3 - 4 years ( odds ratio ( OR ) 5.8 ) .", "label": "", "metadata": {}, "score": "71.03748"}
{"text": "The first patient was a 63-year - old man who was hospitalized in January 2010 , initially on a surgical ward , and then scheduled for a liver transplant .", "label": "", "metadata": {}, "score": "71.061905"}
{"text": "She never had CRKP , and never received colistin - but in the middle of May , she was discovered to have a urinary tract infection that was colistin - resistant .", "label": "", "metadata": {}, "score": "71.314"}
{"text": "This protocol was further refined by the Copenhagen group to increase the duration of treatment with oral ciprofloxacin and aerosolized colistin to three months .At the Leeds CF centre we use three months of nebulised colistin in combination with oral ciprofloxacin on first isolation of P. aeruginosa .", "label": "", "metadata": {}, "score": "71.34407"}
{"text": "However , they found low penetration level ( 5 % ) suggesting inadequate bactericidal colistin concentrations in the CSF .The treatment of postneurosurgical meningitis or ventriculitis or CNS shunt infection due to MDR GNB , such as A. baumannii and P. aeruginosa , is a difficult clinical problem and is associated with high mortality rates mainly due to the limited penetration of colistin into the CSF .", "label": "", "metadata": {}, "score": "71.375694"}
{"text": "In total , 41 patients with bacteremia or ventilator - associated pneumonia caused by carbapenemase - producing K. pneumoniae were treated with a median dose of 24 g of fosfomycin per day for a total of 14 days .", "label": "", "metadata": {}, "score": "71.43179"}
{"text": "This strategy relates to all potential routes of colistin administration to maximize colistin clinical efficacy associated with minimal adverse effects .In addition , there is discrepancy regarding the recommended doses of colistin ( CMS ) worldwide .", "label": "", "metadata": {}, "score": "71.50132"}
{"text": "Based on these findings , it seems that the reported daily colistin dose of 6 m. units ( 2 m. units administered every 8 hours ) resulted in suboptimal serum colistin concentrations and undetectable colistin concentrations in BAL in critically ill patients [ 10 ] .", "label": "", "metadata": {}, "score": "71.55237"}
{"text": "The PKs of three different CMS daily doses ( 3 m. units every 8 h 4.5 m. units every 12 h and 9 m. units every 24 h ) have been recently examined by Daikos et al .", "label": "", "metadata": {}, "score": "71.564705"}
{"text": "A small safety study found no serious adverse events ( Conway et al , 2000 ) ; we regularly administer bolus colistin to patients with Port - A - Caths or PAS ports .", "label": "", "metadata": {}, "score": "71.649506"}
{"text": "KPRC was also associated with the performance of invasive procedures and the duration of mechanical ventilation prior to infection .In this respect , our study suggests that infection control policies should reinforce measures to prevent excessive antibiotic use and to be cautious with the use of colistin .", "label": "", "metadata": {}, "score": "71.673256"}
{"text": "FTI maintained the substantial improvements in FEV1 % predicted and was well tolerated .Tobramycin versus Colistin .The primary end point was a change in FEV1 % predicted .", "label": "", "metadata": {}, "score": "71.78071"}
{"text": "The conclusion was that CDPI demonstrated efficacy by virtue of noninferiority to TIS in lung function after 24 weeks .Colistin Inhaled versus Placebo .Other Inhaled Antibiotics versus Placebo .", "label": "", "metadata": {}, "score": "71.86455"}
{"text": "After the first few doses , colistin concentrations were below the Clinical and Laboratory Standards Institute MIC breakpoint of 2 mg / L for P. aeruginosa and Enterobacteriaceae .", "label": "", "metadata": {}, "score": "71.9419"}
{"text": "Patients with KPRC colonization were not included in analysis .Mortality analysis was performed between two groups ( survivors and nonsurvivors ) ; age , invasive procedures , total duration of sedation and MV , medical cause of admission , and KPRC infection were assessed as risk factors .", "label": "", "metadata": {}, "score": "71.98161"}
{"text": "Nebulised colistin has proved highly effective in the early eradication of P. aeruginosa infection , resulting in reduced prevalence of chronic infection among children with cystic fibrosis ( Frederiksen et al , 1997 ; Lee et al , 2004 ) .", "label": "", "metadata": {}, "score": "72.03493"}
{"text": "She was suffering from hemorrhagic pancreatitis and was scheduled for a multi - organ transplant ; she went straight to the transplant unit .After she had been there two months , she was also diagnosed with CRKP , and also began receiving colistin .", "label": "", "metadata": {}, "score": "72.084175"}
{"text": "Only one study has directly compared tobramycin nebulised solution ( TOBI \u00ae ) and colistin in the clinical setting .Hodson et al investigated the efficacy of colistin and tobramycin nebulised solution in 115 people with CF who were chronically infected with P. aeruginosa ( Hodson et al , 2002 ) .", "label": "", "metadata": {}, "score": "72.12028"}
{"text": "Most data have been derived from mixed medical and critical care populations ; the prevalence of critically ill patients among those studies is unclear .Moreover , most previous studies were retrospective ; this may insert bias in the interpretation of the results , especially in the diagnosis of KPRC infection , for example , differentiation between infection and colonization .", "label": "", "metadata": {}, "score": "72.191826"}
{"text": "Karageorgopoulos DE , Miriagou V , Tzouvelekis LS , Spyridopoulou K , Daikos GL : Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia : report of three cases .", "label": "", "metadata": {}, "score": "72.287186"}
{"text": "Only 3 % of strains were resistant to colistin , while 40 % were resistant to two or more compounds with ceftazidime in combination with gentamicin , piperacillin or ciprofloxacin being the most common cross resistance ( Schulin , 2002 ) .", "label": "", "metadata": {}, "score": "72.30298"}
{"text": "After three consecutive CMS aerosols , peak tissue concentrations were found higher than MIC , indicating significant distal lung deposition .Although these data seem promising , it is not known whether they can be extrapolated to critically ill patients with MDR nosocomial pneumonia in the ICU setting , who may display different pharmacokinetics parameters compared with patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "72.32272"}
{"text": "In the present investigation , there was also an association between KPRC infection and the duration of MV .Mechanical ventilation is a treatment option that is often necessary in critical illness and it is related with the burden of the disease ; its duration might be considered as a marker of disease severity [ 28 ] .", "label": "", "metadata": {}, "score": "72.47"}
{"text": "However , the long - term results of such a approach are unknown and warrant further investigation .Regarding the early chronic suppressive therapy , there have been many studies with variable results .", "label": "", "metadata": {}, "score": "72.726746"}
{"text": "In order to advance the care of CF patients , controlled clinical trials are needed to find the optimal approach for managing CF patients who are infected with either MSSA or MRSA .", "label": "", "metadata": {}, "score": "72.72705"}
{"text": "In renal failure , the renal excretion of CMS is decreased resulting in a higher conversion to colistin and prolongation of half - life [ 3 ] .", "label": "", "metadata": {}, "score": "72.73129"}
{"text": "Intravenous ( IV ) Antibiotics with or without Inhaled and/or Oral Antibiotics .In a pilot study [ 51 ] in 28 patients aged from 2 to 18 years , the authors gave a two - week course of azlocillin ( 150 mg / kg / d ) and tobramycin ( 10 - 15 mg / kg / d ) .", "label": "", "metadata": {}, "score": "72.8786"}
{"text": "Steady - state pharmacokinetics of colistin has been recently examined in 13 adult patients with ventilator - associated pneumonia ( VAP ) caused by GNB .", "label": "", "metadata": {}, "score": "72.915085"}
{"text": "Studies on a new dry powder formulation of colistin are in progress and the provisional results are encouraging ( Le Brun et al , 2002 ; de Boer et al , 2002 ; Westerman et al , 2005 ) .", "label": "", "metadata": {}, "score": "72.94"}
{"text": "Secondary end points included change in P. aeruginosa density , change in MIC and safety .Both treatments reduced the bacterial load .This study had a few weaknesses in its design .", "label": "", "metadata": {}, "score": "72.96269"}
{"text": "The authors evaluated the bactericidal activity of serum containing various concentrations of colistin against P. aeruginosa with a MIC 1 \u03bcg / ml .Mean serum C ( max ) of colistin were 3.34 , 2.98 , and 5.63 \u03bcg / ml , respectively .", "label": "", "metadata": {}, "score": "72.994705"}
{"text": "Furthermore , our study questions the usefulness of SDD policies which include colistin , in ICU settings where KPRC is prevalent .In our unit we do not use decontamination strategies with colistin and we therefore can not provide data in this issue .", "label": "", "metadata": {}, "score": "73.16398"}
{"text": "View Article .Fern\u00e1ndez - Viladrich P , Corbella X , Corral L , Tubau F , Mateu A : Successful treatment of ventriculitis due to carbapenem - resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium .", "label": "", "metadata": {}, "score": "73.18872"}
{"text": "The treatment regimen differs depending upon whether outpatient or inpatient therapy is indicated .If inpatient therapy is indicated , then iv vancomycin or teicoplanin are the drugs of choices .", "label": "", "metadata": {}, "score": "73.33193"}
{"text": "[54 ] included 24 patients and used IV ticarcillin clavulanate plus tobramycin for 2 weeks , followed by oral ciprofloxacin or inhaled tobramycin for 3 months .", "label": "", "metadata": {}, "score": "73.47687"}
{"text": "Despite these challenges , there is only a few evidence - based data regarding the risk factors associated with increased frequency of KPRC infection .In the present prospective study , we aimed to identify possible risk factors for KPRC infection in the critical care setting .", "label": "", "metadata": {}, "score": "73.545265"}
{"text": "PubMed ] .Rynn C , Wootton M , Bowker KE , et al .In vitro assessment of colistin 's anti - Pseudomonal antimicrobial interactions with other antibiotics .", "label": "", "metadata": {}, "score": "73.59169"}
{"text": "Consultations from experts in the treatment of infections with multidrug - resistant organisms may also prove valuable in patient management .The following antimicrobial therapies have been used with various levels of success in the treatment of CRE infections .", "label": "", "metadata": {}, "score": "73.680466"}
{"text": "Also a significant reduction ( 61 - 79 % ) in the need for other antimicrobials was observed with all MP-376 treatment groups .In a crossover study , the authors included 20 participants of 15 - 42 years age and administered carbenicillin ( 1 g ) and gentamicin ( 80 mg ) BID for 6 months [ 63 ] .", "label": "", "metadata": {}, "score": "73.72936"}
{"text": "Colistin is an old antibiotic and potentially toxic to kidneys that has been used increasingly during the last years due to the emergence of Gram - negative MDR bacteria .", "label": "", "metadata": {}, "score": "73.74646"}
{"text": "PubMed View Article .Li J , Rayner CR , Nation RL , Deans R , Boots R , Widdecombe N , Douglas A , Lipman J : Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration .", "label": "", "metadata": {}, "score": "73.80307"}
{"text": "The emergence of resistance to fosfomycin during therapy for bacteremia with KPC K. pneumoniae has been reported and is especially concerning since fosfomycin was used as an adjunct in combination therapy in these cases [ 58 ] .", "label": "", "metadata": {}, "score": "73.8851"}
{"text": "Nevertheless , in 2010 , the FDA added a warning regarding the risk of increased mortality with tigecycline treatment , especially for non - approved indications such as hospital- or ventilator - associated pneumonias ( found at [ 53 ] ) .", "label": "", "metadata": {}, "score": "73.934616"}
{"text": "Second , not all trials are reported on each key outcome and outcomes are not reported in a consistent format .Direction for Future Research .", "label": "", "metadata": {}, "score": "73.97525"}
{"text": "administration .Half - life elimination : 2 - 3 h ( CMS i.v .administration , with normal renal function ) .For colistin ( base ) : 250 min .", "label": "", "metadata": {}, "score": "74.01143"}
{"text": "48 hours during a 12-month period .Clinical and microbiologic data were studied .Characteristics of KPRC patients were compared with those of critically ill patients who presented nonmultidrug resistant ( MDR ) bacterial infections or no documented infection at all .", "label": "", "metadata": {}, "score": "74.0159"}
{"text": "Institutional review board approved the study that was conducted in accordance with current institutional regulations .Outcome .Identification of risk factors for the first episode of KPRC infection in ICU was the primary outcome in this study .", "label": "", "metadata": {}, "score": "74.030426"}
{"text": "3 These strategies should be urgently implemented in all our hospitals .Urinary catheters should only be used in those patients who have appropriate indications , should be removed as soon as possible , and should have sterile , closed drainage systems .", "label": "", "metadata": {}, "score": "74.09814"}
{"text": "3 These strategies should be urgently implemented in all our hospitals .Urinary catheters should only be used in those patients who have appropriate indications , should be removed as soon as possible , and should have sterile , closed drainage systems .", "label": "", "metadata": {}, "score": "74.09814"}
{"text": "3 These strategies should be urgently implemented in all our hospitals .Urinary catheters should only be used in those patients who have appropriate indications , should be removed as soon as possible , and should have sterile , closed drainage systems .", "label": "", "metadata": {}, "score": "74.09814"}
{"text": "[PubMed ] .Li J , Turnidge J , Milne R , et al .In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "74.09944"}
{"text": "Conclusions .Whereas colistin is mainly administered i.v .in critically ill patients , it can be safely be administered by inhalation in patients with pneumonia / VAP or intrathecally in patients with meningitis due to MDR GNB .", "label": "", "metadata": {}, "score": "74.120865"}
{"text": "Prevalence of P. aeruginosa resistance to colistin .A recent survey of reported susceptibility to six commonly prescribed antibiotics of isolates of P. aeruginosa from 417 people with CF from 17 hospitals ( Pitt et al , 2003 ) .", "label": "", "metadata": {}, "score": "74.16636"}
{"text": "The intelligent use of antimicrobials and effective infection control strategies is crucial to prevent further CRE spread .Early consultation with experts in the treatment of infections with multidrug - resistant organisms is valuable in patient management .", "label": "", "metadata": {}, "score": "74.18558"}
{"text": "The addition of colistin to other anti - Pseudomonal drugs also appears to produce greater killing of P. aeruginosa than monotherapy ( Rynn et al , 1999 ) .", "label": "", "metadata": {}, "score": "74.207695"}
{"text": "1 , no . 1 , article 30 , 2011 .View at Publisher \u00b7 View at Google Scholar .M. Ziaka , S. L. Markantonis , M. Fousteri et al . , \" Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection , \" Antimicrob Agents Chemother , vol .", "label": "", "metadata": {}, "score": "74.21559"}
{"text": "10.1128/AAC.00103 - 06 PubMed Central PubMed View Article .Bergen PJ , Li J , Nation RL , Turnidge JD , Coulthard K , Milne RW : Comparison of once- , twice- and thrice daily dosing of colistin on antibacterial effect and emergence of resistance : studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model .", "label": "", "metadata": {}, "score": "74.24786"}
{"text": "When evaluated in a randomized controlled trial of hospital - acquired pneumonia , tigecycline plus ceftazidime was inferior to vancomycin and imipenem - cilastatin for the treatment of ventilator - associated pneumonia [ 50 ] .", "label": "", "metadata": {}, "score": "74.31719"}
{"text": "Bergen et al .[ 8 ] examined the pharmacokinetics of colistin in an in vitro pharmacokinetic / pharmacodynamic model .Three intermittent dosage regimens involving 8-h , 12-h , and 24-h dosage intervals ( Cmax of 3.0 , 4.5 , or 9.0 mg / L , respectively ) were administered in humans .", "label": "", "metadata": {}, "score": "74.33304"}
{"text": "[PubMed ] .Li J , Nation RL , Milne RW , et al .Evaluation of colistin as an agent against multi - resistant Gram negative bacteria .", "label": "", "metadata": {}, "score": "74.35594"}
{"text": "Manufacturers of the U.S. colistin product , Coly - Mycin , recommend a dose of 2.5 to 5 mg / kg colistin base activity daily divided in 2 to 4 doses .", "label": "", "metadata": {}, "score": "74.37489"}
{"text": "( Poster 288 ) .Westerman EM , de Boer EH , Le Brun PPH , et al .Colistin dry powder inhalation in cystic fibrosis : novel Twincer inhaler compared to nebulisation : a pilot study .", "label": "", "metadata": {}, "score": "74.38513"}
{"text": "9286 , pp .983 - 984 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. L. Gibson , J. Emerson , N. Mayer - Hamblett et al . , \" Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "74.4129"}
{"text": "Patients with highly resistant pathogens detected in sputum cultures may still derive clinical benefits from aerosolized antibiotics .This may be due to the substantial pharmacodynamic benefits of aerosolized antibiotics ; that is , high concentrations of drug can be delivered to the site of infection with low risk of toxicity .", "label": "", "metadata": {}, "score": "74.42561"}
{"text": "Risk Factors for KPRC Infection .Baseline characteristics between groups are not significantly different and are presented in Table 1 .Prior use and the duration of administration of specific antibiotics , the duration of MV , and the performance of invasive procedures were significantly associated with KPRC infection ( Tables 2 and 3 ) .", "label": "", "metadata": {}, "score": "74.47177"}
{"text": "It is therefore vital that a formal challenge with pre and post inhalation lung function should be undertaken before instituting therapy .Bronchoconstriction can be prevented or lessened by the addition of a beta-2 agonist either before or during nebulisation .", "label": "", "metadata": {}, "score": "74.476746"}
{"text": "947 - 956 , 2013 .View at Google Scholar .M. W. Konstan , D. E. Geller , P. Mini\u0107 , F. Brockhaus , J. Zhang , and G. Angyalosi , \" Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis : the EVOLVE trial , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "74.49596"}
{"text": "Clinically selected colistin - resistant organisms , once emerged , have a potential to persist in the patients and the hospital environment and cause subsequent transmission .", "label": "", "metadata": {}, "score": "74.52545"}
{"text": "Our unit practices the respiratory bundle suggested by the CDC [ 19 ] unless contraindicated .Oral decontamination was performed daily with the use of chlorhexidine , while prophylactic local antibiotics as part of Selective Oropharyngeal or Selective Digestive Decontamination ( SDD ) was not applied .", "label": "", "metadata": {}, "score": "74.5384"}
{"text": "The recommended doses of CMS in patients with normal renal function , those with renal failure , and those who undergo renal replacement therapy or peritoneal dialysis are presented in Table 2 .", "label": "", "metadata": {}, "score": "74.59815"}
{"text": "[PubMed ] .Price DJE , Graham DI .Effect of large doses of colistin sulphomethate on renal function .BMJ 1970 ; 4:525 - 527 .", "label": "", "metadata": {}, "score": "74.67523"}
{"text": "Adverse effects and contraindications .Colistin and renal disease .Dosage must be decreased in patients with renal dysfunction .Avoid using with aminoglycosides and other nephrotoxic drugs such as non - steroidal anti - inflammatory drugs .", "label": "", "metadata": {}, "score": "74.788506"}
{"text": "colistin for infections caused by MDR - GNB .The clearance of CMS was 13.7 L / h .For colistin , the estimated half - life was 14.4 h.", "label": "", "metadata": {}, "score": "74.83009"}
{"text": "Four of the patients received imipenem along with minocycline .Although testing revealed that the MDR - ABC isolates were resistant to imipenem in these cases , it is possible that it still maintained some activity in vivo or provided some synergy with minocycline , thus biasing our results in favor of minocycline therapy .", "label": "", "metadata": {}, "score": "75.03149"}
{"text": "11 - 20 , 2007 .View at Google Scholar \u00b7 View at Scopus . I. B. MacLusky , R. Gold , M. Corey , and H. Levison , \" Long - term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa , \" Pediatric pulmonology , vol .", "label": "", "metadata": {}, "score": "75.0939"}
{"text": "Li J , Nation RL , Milne RW , Turnidge JD , Coulthard K : Evaluation of colistin as an agent against multi - resistant Gram - negative bacteria .", "label": "", "metadata": {}, "score": "75.16833"}
{"text": "Participants randomized to cycled therapy received TIS for 28 days , with oral ciprofloxacin or oral placebo for 14 days every quarter , while participants randomized to culture - based therapy received the same treatments only during quarters with positive P. aeruginosa cultures .", "label": "", "metadata": {}, "score": "75.26126"}
{"text": "[ Improves clinical status and exercise capacity when added to conventional therapy ] .Clifton I , Denton M , Etherington C , et al .", "label": "", "metadata": {}, "score": "75.281136"}
{"text": "Subjects were excluded if they received a course of therapy with another active antimicrobial before receiving minocycline .Information extracted from chart review included age , sex , site of infection , type of injury , type and duration of antimicrobial therapy received , presence of copathogens , outcome , and length of follow - up .", "label": "", "metadata": {}, "score": "75.28775"}
{"text": "Mullinger B , Brand P , Pechtold O , et al .In vitro based comparison of deposition efficiency of two inhalations systems for inhalation of colistin .", "label": "", "metadata": {}, "score": "75.34688"}
{"text": "4 , p. S100 , 2005 .View at Google Scholar .J. Wolter , S. Seeney , S. Bell , S. Bowler , P. Masel , and J. McCormack , \" Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis : a randomised trial , \" Thorax , vol .", "label": "", "metadata": {}, "score": "75.37811"}
{"text": "The clinical experience with polymyxin B in treatment of CRE infections is limited to small case series .These patients with pneumonia , bloodstream , urinary tract , or skin and soft tissue infections were given a polymyxin B dose of 25,000 or 15,000 IU / kg for a creatinine clearance of at least 50 mL / minute or less than 50 mL / minute , respectively .", "label": "", "metadata": {}, "score": "75.4597"}
{"text": "[PubMed ] .Clifton I , Peckham D , Conway SP.10 years of use of colistin in a regional cystic fibrosis centre .J Cystic Fibrosis Med 2005 202:S54 .", "label": "", "metadata": {}, "score": "75.46315"}
{"text": "Dose of intravenous colistin .Children - ( Up to 60 kg ) 50,000 to 75,000 units / kg bodyweight per day in three divided doses .", "label": "", "metadata": {}, "score": "75.586975"}
{"text": "[Links ] .Kritsotakis EI , Tsioutis C , Roumbelaki M , et al .Antibiotic use and the risk of carbapenem - resistant extended - spectrum - P - lactamase - producing Klebsiella pneumoniae infection in hospitalized patients : results of a double case - control study .", "label": "", "metadata": {}, "score": "75.60084"}
{"text": "[Links ] .Kritsotakis EI , Tsioutis C , Roumbelaki M , et al .Antibiotic use and the risk of carbapenem - resistant extended - spectrum - P - lactamase - producing Klebsiella pneumoniae infection in hospitalized patients : results of a double case - control study .", "label": "", "metadata": {}, "score": "75.60084"}
{"text": "[Links ] .Kritsotakis EI , Tsioutis C , Roumbelaki M , et al .Antibiotic use and the risk of carbapenem - resistant extended - spectrum - P - lactamase - producing Klebsiella pneumoniae infection in hospitalized patients : results of a double case - control study .", "label": "", "metadata": {}, "score": "75.60084"}
{"text": "4 , pp .356 - 360 , 1987 .View at Google Scholar \u00b7 View at Scopus .P. Latzin , M. Fehling , A. Bauernfeind , D. Reinhardt , M. Kappler , and M. Griese , \" Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis , \" Journal of Cystic fibrosis , vol .", "label": "", "metadata": {}, "score": "75.93856"}
{"text": "These regimens are discussed below .Tobramycin ( Inhaled ) versus Placebo or Other Antibiotics .A Cochrane review ( CR ) [ 36 ] including 2 RCTs [ 37 , 38 ] , and another new RCT [ 39 ] were analyzed .", "label": "", "metadata": {}, "score": "76.08847"}
{"text": "Ciprofloxacin , Colistin , and Tobramycin versus Control .Vazquez et al .[50 ] included 16 patients and used oral ciprofloxacin ( 30 - 40 mg / kg / d ) for 2 weeks , inhalations of colistin ( 1 million units ) , and inhaled tobramycin ( 100 mg BID ) for long term .", "label": "", "metadata": {}, "score": "76.096085"}
{"text": "Antimicrob Agents Chemother 2013 , 57 : 1756 - 1762 .10.1128/AAC.01232 - 12362333623357775 View Article PubMed Central PubMed .Endimiani A , Patel G , Hujer KM , Swaminathan M , Perez F , Rice LB , Jacobs MR , Bonomo RA : In vitro activity of fosfomycin against blaKPC - containing Klebsiella pneumoniae isolates , including those nonsusceptible to tigecycline and/or colistin .", "label": "", "metadata": {}, "score": "76.09672"}
{"text": "Le Brun P P H , de Boer A H , Mannes G P M , et al .Dry powder inhalation of antibiotics in cystic fibrosis therapy : part 2 .", "label": "", "metadata": {}, "score": "76.16472"}
{"text": "One RCT [ 46 ] and three cohort studies [ 47 - 49 ] were included .The RCT by Valerius et al .[46 ] included 26 participants and used oral ciprofloxacin ( 250 - 750 mg BID ) and inhalations of colistin ( 1 million units BID ) for 3 weeks .", "label": "", "metadata": {}, "score": "76.296326"}
{"text": "10.1378/chest.10 - 0463 PubMed View Article .Dudhani RV , Turnidge JD , Coulthard K , Milne RW , Rayner CR , Li J , Nation RL : Elucidation of the pharmacokinetic / pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models .", "label": "", "metadata": {}, "score": "76.4156"}
{"text": "A randomized crossover study compared three treatment groups : ceftazidime , gentamicin and carbenicillin , and saline , each given for 4 months [ 66 ] .", "label": "", "metadata": {}, "score": "76.44611"}
{"text": "Conclusions .References .K. S. McCoy , A. L. Quittner , C. M. Oermann , R. L. Gibson , G. Z. Retsch - Bogart , and A. B. Montgomery , \" Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis , \" American Journal of Respiratory and Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "76.486404"}
{"text": "Furthermore , the dose of colistin prescribed could be regarded as suboptimal as most adult CF units in the UK now prescribe 2 mega units b.d . as the standard dose for people over 2 years of age .", "label": "", "metadata": {}, "score": "76.582825"}
{"text": "Similarly , colistin - polymyxin B combined with carbapenem had a mortality of 12.5 % ( 1 out of 6 ) versus 66.7 % ( 8 out of 12 ) in a study of patients with bacteremia caused by KPC - producing K. pneumoniae bacteremia [ 22 ] .", "label": "", "metadata": {}, "score": "76.60884"}
{"text": "10 , pp .957 - 969 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. M\u00e1iz , R. Del Campo , M. Castro , D. Guti\u00e9rrez , R. Gir\u00f3n , and R. C. Moreno , \" Maintenance treatment with inhaled ampicillin in patients with cystic fibrosis and lung infection due to methicillin - sensitive Staphylococcus aureus , \" Archivos de Bronconeumolog\u00eda , vol .", "label": "", "metadata": {}, "score": "76.67134"}
{"text": "42 - 48 , 1989 .View at Google Scholar \u00b7 View at Scopus .T. D. Murphy , R. D. Anbar , L. A. Lester et al . , \" Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "76.6797"}
{"text": "4 , pp .314 - 320 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. B. Ramsey , M. S. Pepe , and J. M. Quan , \" Intermittent administration of inhaled tobramycin in patients with cvstic fibrosis , \" Pneumologie , vol .", "label": "", "metadata": {}, "score": "76.73047"}
{"text": "[PubMed ] .Li J. Turnidge J , Coulthard K , Milne R , et al .Steady state pharmacokinetics of intravenous colistin methanesulfonate in patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "76.74437"}
{"text": "Chest 2005 ; 127 : 522 - 529 .[PubMed ] .Bosso JA .Liptak CA , Seilheimer DK , et al .Toxicity of colistin in cystic fibrosis patients .", "label": "", "metadata": {}, "score": "76.766846"}
{"text": "A relationship between prior carbapenem use and KPRC infection might be expected [ 20 - 24 ] .Carbapenems can destroy the susceptible proportion of strains which is part of patient 's colonies , so opportunistic infection could be accomplished by the resistant one .", "label": "", "metadata": {}, "score": "76.89291"}
{"text": "The organism - which was identical in four of the patients and negligibly different in the fifth - still responded to tigecycline , a relatively new drug .", "label": "", "metadata": {}, "score": "76.90027"}
{"text": "A better understanding of the pharmacokinetic - pharmacodynamic relationship of colistin is urgently needed to determine the optimal dosing regimen .Although pharmacokinetic and pharmacodynamic data in ICU patients are scarce , recent evidence shows that the pharmacokinetics / pharmacodynamics of colistimethate sodium and colistin in critically ill patients differ from those previously found in other groups , such as cystic fibrosis patients .", "label": "", "metadata": {}, "score": "76.91329"}
{"text": "However , in humans , colistin is not absorbed from the gastrointestinal tract and no biliary excretion has been reported .Based on the study by Owen et al .", "label": "", "metadata": {}, "score": "76.93181"}
{"text": "4 , pp .585 - 594 , 1987 .View at Google Scholar \u00b7 View at Scopus .T. Jensen , S. S. Pedersen , N. Hoiby , and C. Koch , \" Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis , \" European Journal of Clinical Microbiology , vol .", "label": "", "metadata": {}, "score": "76.95691"}
{"text": "47 - 58 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. M. Oermann , G. Z. Retsch - bogart , A. L. Quittner et al . , \" An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "76.98929"}
{"text": "Kontopoulou K , Protonotariou E , Vasilakos K , et al Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 \u00e2 - lactamase resistant to colistin J Hosp Infect 2010;76:70 - 73 .", "label": "", "metadata": {}, "score": "77.03146"}
{"text": "Kontopoulou K , Protonotariou E , Vasilakos K , et al Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 \u00e2 - lactamase resistant to colistin J Hosp Infect 2010;76:70 - 73 .", "label": "", "metadata": {}, "score": "77.03146"}
{"text": "Kontopoulou K , Protonotariou E , Vasilakos K , et al Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 \u00e2 - lactamase resistant to colistin J Hosp Infect 2010;76:70 - 73 .", "label": "", "metadata": {}, "score": "77.03146"}
{"text": "Although these findings have been reported with minocycline use , they seem to be very rare .12 The more commonly reported adverse effects of minocycline use , such as gastrointestinal disturbance , skin or mucous membrane pigmentation , vestibular dysfunction , and hepatotoxicity , were not seen in this cohort .", "label": "", "metadata": {}, "score": "77.17055"}
{"text": "10.1128/AAC.02399 - 12363290223439635 View Article PubMed Central PubMed .Ceccarelli G , Falcone M , Giordano A , Mezzatesta ML , Caio C , Stefani S , Venditti M : Successful ertapenem - doripenem combination treatment of bacteremic ventilator - associated pneumonia due to colistin - resistant KPC - producing Klebsiella pneumoniae .", "label": "", "metadata": {}, "score": "77.29062"}
{"text": "However , more evidence , from trials of longer duration , is needed to determine whether this benefit is maintained and to determine the significance of development of antibiotic - resistant organisms .", "label": "", "metadata": {}, "score": "77.38275"}
{"text": "Precise dose delivery of colistimethate sodium using prototype I - neb AAD system .J Cyst Fibros 2005 ; 4 ( Suppl 1 ) : S30 ( poster 109 ) .", "label": "", "metadata": {}, "score": "77.496185"}
{"text": "There are a couple of observations that can be teased out of these cases .The first is that these infections tend to happen to people who are already very sick : in need of a transplant ; or having gotten a transplant , and on immune system - suppressing drugs ; or with traumatic injury .", "label": "", "metadata": {}, "score": "77.57967"}
{"text": "PubMed ] .Also note recent relevant communications:- .Bugge B , Rosenvinge A , Pressler T , et al .High dose intravenous colistin once a day is a safe and effective treatment of multi - resistant Pseudomonas aeruginosa in adults with cystic fibrosis .", "label": "", "metadata": {}, "score": "77.621826"}
{"text": "10.1128/AAC.00903 - 09 PubMed Central PubMed View Article .Imberti R , Cusato M , Villani P , Carnevale L , Iotti GA , Langer M , Regazzi M : Steady - state pharmacokinetics and bronchoalveolar lavage concentration of colistin in critically - ill patients after intravenous colistin methanesulphonate administration .", "label": "", "metadata": {}, "score": "77.65432"}
{"text": "Colistin may be given as a bolus through a central venous access device with two Mega units being diluted in 10 ml NaCl 0.9 % and given over three to five minutes ( Conway et al , 2000 ) .", "label": "", "metadata": {}, "score": "77.65561"}
{"text": "Hypersensitivity - Myasthenia gravis ( Gold & Richardson , 1965 ) - Pregnancy .Important drug interactions .-Alendronate , etidronate- increased risk of hypocalcaemia - Aminoglycosides - increases risk of nephrotoxicity , reduce doses if concurrent use essential - Amphotericin -increased risk of nephrotoxicity - Loop diuretics - increased risk of ototoxicity - Muscle relaxants - enhance muscle relaxant effect .", "label": "", "metadata": {}, "score": "77.66243"}
{"text": "View at Google Scholar .R. L. Gibson , J. Emerson , S. McNamara et al . , \" Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis , \" American Journal of Respiratory and Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "77.73149"}
{"text": "[Said to be more efficient with no bronchocontriction ] .Goldman MH . \"MU ( 160 mg ) Colistimethate twice daily is a safe nebulized dose for adults and children with cystic fibrosis .", "label": "", "metadata": {}, "score": "77.82418"}
{"text": "At the same time , GNB resistance to antibiotics is growing over the years and has become an emerging concern in critical care [ 3 ] since the antimicrobial options are very restricted [ 4 ] .", "label": "", "metadata": {}, "score": "77.84448"}
{"text": "Lung function ( FEV1 ) was higher and exacerbations were less in the antibiotic - treated group .Resistance to antibiotics and minor side effects were more in the antibiotic - treated group .", "label": "", "metadata": {}, "score": "77.91977"}
{"text": "10.1093/cid / cir401320232421810751 View Article PubMed Central PubMed .Kontopoulou K , Protonotariou E , Vasilakos K , Kriti M , Koteli A , Antoniadou E , Sofianou D : Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta - lactamase resistant to colistin .", "label": "", "metadata": {}, "score": "77.957855"}
{"text": "It is possible that in these cases of coinfection , it was not the primary pathogen , and clinical response was related more to appropriate treatment of the other pathogen(s ) involved .", "label": "", "metadata": {}, "score": "78.09471"}
{"text": "6 , pp .618 - 622 , 1987 .View at Google Scholar \u00b7 View at Scopus . F. Carswell , C. Ward , D. A. Cook , and D. C. E. Speller , \" A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis , \" British Journal of Diseases of the Chest , vol .", "label": "", "metadata": {}, "score": "78.2032"}
{"text": "4 , pp .630 - 637 , 1979 .View at Google Scholar \u00b7 View at Scopus .L. T. Weaver , M. R. Green , K. Nicholson et al . , \" Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period , \" Archives of Disease in Childhood , vol .", "label": "", "metadata": {}, "score": "78.26727"}
{"text": "In some patients , IV ceftazidime and tobramycin were also used .Initial P. aeruginosa colonization was successfully eradicated in 15 of 17 patients for at least two years .", "label": "", "metadata": {}, "score": "78.29779"}
{"text": "PubMed ] .Vazquez C , Municio M , Corera M , et al .Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis .Acta Paediatr 1993 ; 82:308 - 309 .", "label": "", "metadata": {}, "score": "78.36858"}
{"text": "There was an improvement in lung function noted before the intervention .In another cohort study [ 41 ] , 36 young children treated with TSI ( tobramycin solution for inhalation ) 300 mg BID for 28 days or 56 days eradicated P. aeruginosa for up to 3 months after treatment .", "label": "", "metadata": {}, "score": "78.374756"}
{"text": "5 , pp .821 - 826 , 1982 .View at Google Scholar \u00b7 View at Scopus .T. Jensen , S. Lanng , M. Faber , V. T. Rosdahl , N. Hoiby , and C. Koch , \" Clinical experiences with fusidic acid in cystic fibrosis patients , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "78.47379"}
{"text": "Colistin ( base ) is more active than CMS .CMS is eliminated predominantly by the kidneys .It should be noted that after CMS i.v .", "label": "", "metadata": {}, "score": "78.476"}
{"text": "Quinn AL , Parada JP , Belmares J , O'Keefe JP : Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection .Ann Pharmacother 2005 , 39 : 949 - 952 .", "label": "", "metadata": {}, "score": "78.49379"}
{"text": "Pharmacy records were used to identify all patients who received minocycline at any time during 2005 and 2006 .Chart review of electronic inpatient and outpatient records was then performed to identify which of these patients received minocycline for a traumatic wound infection caused by MDR - ABC .", "label": "", "metadata": {}, "score": "78.500305"}
{"text": "21 - 31 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Lenoir , Y. G. Antypkin , A. Miano et al . , \" Efficacy , safety , and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa , \" Pediatric Drugs , vol .", "label": "", "metadata": {}, "score": "78.661255"}
{"text": "Appropriate empirical antimicrobial treatment referred to administration at least one of in vitro active antimicrobials against the study isolates within 24 hrs from infection onset .", "label": "", "metadata": {}, "score": "78.68057"}
{"text": "De Boer AH , Le Brun PP , van der Woude HG , et al .Dry powder inhalation of antibiotics in cystic fibrosis therapy , Part 1 : development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de - agglomeration principle .", "label": "", "metadata": {}, "score": "78.90266"}
{"text": "3893 - 3896 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Leavitt , S. Navon - Venezia , I. Chmelnitsky , M. J. Schwaber , and Y. Carmeli , \" Emergence of KPC-2 and KPC-3 in carbapenem - resistant Klebsiella pneumoniae strains in an Israeli hospital , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "78.9103"}
{"text": "31 , no . 1 , pp .13 - 16 , 2001 .View at Google Scholar . H. R. Stutman , J. M. Lieberman , E. Nussbaum , and M. I. Marks , \" Antibiotic prophylaxis in infants and young children with cystic fibrosis : a randomized controlled trial , \" Journal of Pediatrics , vol .", "label": "", "metadata": {}, "score": "78.93507"}
{"text": "PubMed View Article .Jajoo M , Kumar V , Jain M , Kumari S , Manchanda V : Intravenous colistin administration in neonates .Pediatr Infect Dis J 2011 , 30 : 218 - 221 . 10.1097/INF.0b013e3182064bfe PubMed View Article .", "label": "", "metadata": {}, "score": "78.960976"}
{"text": "PubMed ] .Jensen T , Pedersen SS , Garne S , et al .Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection .", "label": "", "metadata": {}, "score": "78.990295"}
{"text": "View Article PubMed .Lee J , Patel G , Huprikar S , Calfee DP , Jenkins SG : Decreased susceptibility to polymyxin B during treatment for carbapenem - resistant Klebsiella pneumoniae infection .", "label": "", "metadata": {}, "score": "78.99031"}
{"text": "Therefore the question to optimize antibiotic treatment is a crucial issue in CF care and , basically , the approach of a survey on evidence based antimicrobial therapy in CF can give some - but possibly limited - answers to this basal question .", "label": "", "metadata": {}, "score": "78.99771"}
{"text": "Antimicrobial susceptibilities were performed using disk diffusion or broth microdilution testing per Clinical and Laboratory Standards Institute guidelines .Because a previous study revealed that MDR - ABC at our institution typically remains susceptible to minocycline , susceptibility testing for this drug was not routinely performed by the laboratory , unless requested by the attending physician .", "label": "", "metadata": {}, "score": "79.00714"}
{"text": "24381080 View Article .Tzouvelekis LS , Markogiannakis A , Psichogiou M , Tassios PT , Daikos GL : Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae : an evolving crisis of global dimensions .", "label": "", "metadata": {}, "score": "79.02171"}
{"text": "3,5,6 Because these types of infections are often associated with poor bone healing and delayed union , most clinicians in our institution opt to treat these empirically as osteomyelitis .", "label": "", "metadata": {}, "score": "79.07822"}
{"text": "Colistin 's pharmacokinetic properties .The main pharmacokinetics ( PK ) of colistin are presented in Table 1 .Few studies have addressed the PKs of CMS and colistin in humans , especially in the ICU setting .", "label": "", "metadata": {}, "score": "79.084114"}
{"text": "Thus , the MICs should always be determined and taken into account if carbapenems are contemplated as a potential treatment option .Bacterial killing for isolates with MICs of 4 mg / L is more likely with high - dose , prolonged - infusion regimens ( that is , meropenem 2 g IV infused over 3 hours every 8 hours ) [ 32 ] .", "label": "", "metadata": {}, "score": "79.09613"}
{"text": "It seems that the best way to avoid confusion related to colistin dosing is to base the doses on international units .Pure colistin base has been assigned a potency of 30,000 IU per mg , and CMS has a potency of 12,500 IU per mg .", "label": "", "metadata": {}, "score": "79.09985"}
{"text": "A total of 8 patients received minocycline for a traumatic wound infection caused by MDR - ABC .The characteristics of these patients are listed in Table 1 .", "label": "", "metadata": {}, "score": "79.12396"}
{"text": "Markantonis SL , Markou N , Fousteri M , Sakellaridis N , Karatzas S , Alamanos I , Dimopoulou E , Baltopoulos G : Penetration of colistin into cerebrospinal fluid .", "label": "", "metadata": {}, "score": "79.15801"}
{"text": "8433 , p. 865 , 1985 .View at Google Scholar \u00b7 View at Scopus .B. Frederiksen , C. Koch , and N. H\u00f8iby , \" Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "79.18602"}
{"text": "231 - 236 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. A. Garske , T. J. Kidd , R. Gan et al . , \" Rifampicin and sodium fusidate reduces the frequency of methicillin - resistant Staphylococcus aureus ( MRSA ) isolation in adults with cystic fibrosis and chronic MRSA infection , \" Journal of Hospital Infection , vol .", "label": "", "metadata": {}, "score": "79.20279"}
{"text": "130 - 140 , 2013 .View at Publisher \u00b7 View at Google Scholar .B. C. Trapnell , S. A. McColley , D. G. Kissner et al . , \" Fosfomycin / tobramycin for inhalation in patients with cystic fibrosis with Pseudomonas airway infection , \" American Journal of Respiratory and Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "79.20885"}
{"text": "10.1128/AAC.01361 - 08 PubMed Central PubMed View Article .Daikos GL , Skiada A , Pavleas J , Vafiadi C , Salatas K , Tofas P , Tzanetou K , Markogiannakis A , Thomopoulos G , Vafiadi I , Petrikkos G : Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use .", "label": "", "metadata": {}, "score": "79.209366"}
{"text": "4 , pp .234 - 242 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Chuchalin , E. Csisz\u00e9r , K. Gyurkovics et al . , \" A formulation of aerosolized tobramycin ( Bramitob ) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection : a double - blind , placebo - controlled , multicenter study , \" Pediatric Drugs , vol .", "label": "", "metadata": {}, "score": "79.28434"}
{"text": "4 , pp .1938 - 1940 , 2013 .View at Google Scholar . A. Polito , E. Patorno , J. M. Costello et al . , \" Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery , \" Pediatric Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "79.33099"}
{"text": "10.1016/j.ijantimicag.2009.10.005 PubMed View Article .Falagas ME , Fragoulis KN , Kasiakou SK , Sermaidis GJ , Michalopoulos A : Nephrotoxicity of intravenous colistin : a prospective evaluation .", "label": "", "metadata": {}, "score": "79.40802"}
{"text": "View at Google Scholar .R. Cant\u00f3n , N. Cobos , J. de Gracia et al . , \" Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients , \" Clinical Microbiology and Infection , vol .", "label": "", "metadata": {}, "score": "79.42796"}
{"text": "10.1016/j.ijantimicag.2004.10.001 PubMed View Article .Froman J , Gross L , Curatola S : Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals .", "label": "", "metadata": {}, "score": "79.467316"}
{"text": "View Article PubMed Central PubMed .Zavascki AP , Goldani LZ , Cao G , Superti SV , Lutz L , Barth AL , Ramos F , Boniatti MM , Nation RL , Li J : Pharmacokinetics of intravenous polymyxin B in critically ill patients .", "label": "", "metadata": {}, "score": "79.50615"}
{"text": "[PubMed ] .Schulin T. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany .", "label": "", "metadata": {}, "score": "79.60268"}
{"text": "Conflict of Interests .Acknowledgment .The authors thank Mrs. Vassiliki Tsilioni ( English Literature graduate ) for her assistance in editing the paper . D. P. Raymond , S. J. Pelletier , T. D. Crabtree , H. L. Evans , T. L. Pruett , and R. G. Sawyer , \" Impact of antibiotic - resistant Gram - negative bacilli infections on outcome in hospitalized patients , \" Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "79.60988"}
{"text": "11 , pp .1643 - 1653 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . L. Saiman , M. Anstead , N. Mayer - Hamblett et al . , \" Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa : a randomized controlled trial , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "79.719666"}
{"text": "In that respect , the low pathogenicity of MDR - ABC would actually be an argument to use a safe oral medicine , such as minocycline , instead of more broad - spectrum or toxic agents , such as colistin and imipenem .", "label": "", "metadata": {}, "score": "79.779686"}
{"text": "PubMed .Gupta S , Govil D , Kakar PN , Prakash O , Arora D , Das S , Govil P , Malhotra A : Colistin and polymyxin B : a re - emergence .", "label": "", "metadata": {}, "score": "79.797195"}
{"text": "The participants received one of three doses of MP-376 ( 120 mg OD , 240 mg OD , 240 mg BID ) or placebo for 28 days .", "label": "", "metadata": {}, "score": "79.855774"}
{"text": "Neither there was co - colonization due to P. aeruginosa nor was MSSA eradicated .Methicillin Resistant S. aureus ( MRSA ) .There are no current guidelines for treatment of MRSA in patients with CF .", "label": "", "metadata": {}, "score": "79.92454"}
{"text": "84 - 89 , 1994 .View at Google Scholar \u00b7 View at Scopus .G. Nolan , P. McIvor , and H. Levison , \" Antibiotic prophylaxis in cystic fibrosis : inhaled cephaloridine as an adjunct to oral cloxacillin , \" Journal of Pediatrics , vol .", "label": "", "metadata": {}, "score": "79.96576"}
{"text": "10.1128/AAC.00345 - 09 PubMed Central PubMed View Article .Falagas M , Rafailidis P , Ioannidou E , Alexiou V , Matthaiou D , Karageorgopoulos D , Kapaskelis A , Nikita D , Michalopoulos A : Colistin therapy for microbiologically documented multidrug - resistant Gram ( - ) bacterial infections : a retrospective cohort study of 258 patients .", "label": "", "metadata": {}, "score": "80.059456"}
{"text": "3,4 This has forced many clinicians to use less conventional antimicrobials , such as colistin or tigecycline , which are unproven for this indication and may result in relatively high rates of toxicity .", "label": "", "metadata": {}, "score": "80.14717"}
{"text": "Int J Antimicrob Agents 2011 , 37 : 415 - 419 .10.1016/j.ijantimicag.2011.01.01221429716 View Article PubMed .Gales AC , Reis AO , Jones RN : Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin : review of available interpretative criteria and quality control guidelines .", "label": "", "metadata": {}, "score": "80.15613"}
{"text": "Poster K-186 .Sader HS , Farrell DJ , Jones RN : Tigecycline activity tested against multidrug - resistant Enterobacteriaceae and Acinetobacter spp . isolated in US medical centers ( 2005 - 2009 ) .", "label": "", "metadata": {}, "score": "80.277596"}
{"text": "[PubMed ] .Gold GN , Richardson AP .An unusual case of neuromuscular blockade seen with therapeutic blood levels of colistin methanesulphate .Am J Med 1965 ; 41:316 - 321 .", "label": "", "metadata": {}, "score": "80.29078"}
{"text": "230 - 238 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Jensen , S. S. Pedersen , and S. Garne , \" Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "80.42069"}
{"text": "[PubMed ] .Littlewood JM , Koch C , Lambert PA , et al .A ten - year review of colomycin .Resp Med 2000 ; 94:632 - 640 .", "label": "", "metadata": {}, "score": "80.57934"}
{"text": "10.1128/AAC.49.11.4814 - 4815.2005 PubMed Central PubMed View Article .Ratjen F , Rietschel E , Kasel D , Schwiertz R , Starke K , Beier H , van Koningsbruggen S , Grasemann H : Pharmacokinetics of inhaled colistin in patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "80.670166"}
{"text": "J Cyst Fibros 2005 ; 4 ( Suppl 1):S54 ( Poster 203 ) .[ 0.4 % of chronically infected patients had colistin resistant strains at some time .", "label": "", "metadata": {}, "score": "80.68086"}
{"text": "Tonicity of colistin solution .Dodd et al conducted a study examining the relationship of chest tightness and change in lung function in response to the inhalation of a range of tonicities of nebulised colistin and their influence on patients ' preference ( Dodd et al , 1997 ) .", "label": "", "metadata": {}, "score": "80.724304"}
{"text": "189 - 195 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Macfarlane , A. Leavy , J. McCaughan , R. Fair , and A. J. M. Reid , \" Successful decolonization of meticillin - resistant Staphylococcus aureus in paediatric patients with cystic fibrosis ( CF ) using a three - step protocol , \" Journal of Hospital Infection , vol .", "label": "", "metadata": {}, "score": "80.93421"}
{"text": "10.1086/517243 PubMed View Article .Gump WC , Walsh JW : Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis : case report and review of the literature .", "label": "", "metadata": {}, "score": "80.94778"}
{"text": "The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas and staphylococcus in cystic fibrosis ( CF ) .We systematically searched all the published literature that has considered the evidence for antimicrobial therapies in CF till June 2013 .", "label": "", "metadata": {}, "score": "81.02023"}
{"text": "299 - 305 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Sol\u00eds , D. Brown , J. Hughes , H. K. F. Van Saene , and D. P. Heaf , \" Methicillin - resistant Staphylococcus aureus in children with cystic fibrosis : an eradication protocol , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "81.02764"}
{"text": "10.1128/JCM.39.1.183 - 190.20018769911136768 View Article PubMed Central PubMed .Falagas ME , Rafailidis PI , Ioannidou E , Alexiou VG , Matthaiou DK , Karageorgopoulos DE , Kapaskelis A , Nikita D , Michalopoulos A : Colistin therapy for microbiologically documented multidrug - resistant Gram - negative bacterial infections : a retrospective cohort study of 258 patients .", "label": "", "metadata": {}, "score": "81.03943"}
{"text": "10.1128/CMR.05035 - 11348575323034326 View Article PubMed Central PubMed .Zavascki AP , Barth AL , Gaspareto PB , Goncalves AL , Moro AL , Fernandes JF , Goldani LZ : Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo - beta - lactamase in two tertiary - care teaching hospitals .", "label": "", "metadata": {}, "score": "81.11245"}
{"text": "We have recently reported our 10 year prevalence of colistin resistance among isolates of P. aeruginosa in the Leeds Adult CF unit ( Clifton et al , 2005 ) .", "label": "", "metadata": {}, "score": "81.13284"}
{"text": "4 , 2009 .View at Google Scholar \u00b7 View at Scopus . H. G. Wiesemann , G. Steinkamp , F. Ratjen , et al . , \" Placebo - controlled , double - blind , randomized study of aerolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "81.21169"}
{"text": "View at Google Scholar .R. J. Stead , M. E. Hodson , and J. C. Batten , \" Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa , \" British Journal of Diseases of the Chest , vol .", "label": "", "metadata": {}, "score": "81.33673"}
{"text": "67 - 91 , 2004 .View at Google Scholar .P. A. Flume , B. P. O'Sullivan , K. A. Robinson et al . , \" Cystic fibrosis pulmonary guidelines : chronic medications for maintenance of lung health , \" American Journal of Respiratory and Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "81.45164"}
{"text": "However , colistin is not active against Burkholderia cepacia , Serratia marcescens , Moraxella catarrhalis , pathogenic Neisseria spp , Proteus spp , Providencia spp , or Morganella morganii [ 14 ] .", "label": "", "metadata": {}, "score": "81.466415"}
{"text": "Alternative antimicrobial agents that are safe and well tolerated are needed .Minocycline has activity against Acinetobacter and has been used by some in the treatment of pneumonia caused by this pathogen .", "label": "", "metadata": {}, "score": "81.522415"}
{"text": "Additional studies were identified through manual searches of reference lists of the originally identified studies as well as reviews on the subject .No language restrictions were applied .", "label": "", "metadata": {}, "score": "81.59788"}
{"text": "every 8 hours , for at least 2 days .Patients received a mean of 2.19 mg / kg of CMS per dose .At steady - state , apparent volume of distribution ( Vd / fm ) was 1.5 \u00b1 1.1 L / kg .", "label": "", "metadata": {}, "score": "81.60491"}
{"text": "3,4 The plasmids that confer such resistance frequently carry additional resistance determinants that confer cross - resistance to most other antibiotic classes .Consequently , prior use of any antibiotic may select for a carbapenemase - producing GNB .", "label": "", "metadata": {}, "score": "81.62106"}
{"text": "3,4 The plasmids that confer such resistance frequently carry additional resistance determinants that confer cross - resistance to most other antibiotic classes .Consequently , prior use of any antibiotic may select for a carbapenemase - producing GNB .", "label": "", "metadata": {}, "score": "81.62106"}
{"text": "3,4 The plasmids that confer such resistance frequently carry additional resistance determinants that confer cross - resistance to most other antibiotic classes .Consequently , prior use of any antibiotic may select for a carbapenemase - producing GNB .", "label": "", "metadata": {}, "score": "81.62106"}
{"text": "[PubMed ] .Koch - Weser J , Sidel VW , Federman EB , et al .Adverse effects of sodium colistin methate : manifestations and specific reaction rates during 317 courses of therapy .", "label": "", "metadata": {}, "score": "81.66929"}
{"text": "Initial P. aeruginosa colonization was successfully eradicated in 23 of 26 patients , and 3 of 23 patients developed recurrences after 1 year .Treatment of Chronically Persistent Airway Colonization with P. aeruginosa .", "label": "", "metadata": {}, "score": "81.70562"}
{"text": "10.1016/j.ijantimicag.2009.06.028 PubMed View Article .Iosifidis E , Antachopoulos C , Ioannidou M , Mitroudi M , Sdougka M , Drossou - Agakidou V , Tsivitanidou M , Roilides E : Colistin administration to pediatric and neonatal patients .", "label": "", "metadata": {}, "score": "81.72384"}
{"text": "J Cyst Fibros 2005 ; 4 ( Suppl 1):S54 ( Poster 202 ) .[Little change in the prevalence of colistin resistance among isolates of Pseudomonas aeruginosa over 10 years despite extensive use ( 0.38 % pa to 2000 and then 0.18 % pa to 2004 ] .", "label": "", "metadata": {}, "score": "81.74463"}
{"text": "10.1128/AAC.01420 - 10310146921422205 View Article PubMed Central PubMed .Giamarellou H , Galani L , Baziaka F , Karaiskos I : Effectiveness of a double - carbapenem regimen for infections in humans due to carbapenemase - producing pandrug - resistant Klebsiella pneumoniae .", "label": "", "metadata": {}, "score": "81.81801"}
{"text": "x21793988 View Article PubMed .Patel G , Huprikar S , Factor SH , Jenkins SG , Calfee DP : Outcomes of carbapenem - resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies .", "label": "", "metadata": {}, "score": "81.87163"}
{"text": "Once the organism is isolated , the therapy depends upon presence or absence of symptoms .Reviewing the available data on the efficacy and safety of aztreonam ( AZLI ) , colistin ( COL ) , and tobramycin ( TOB ) administered by inhalation , we have discussed significant differences among these antibiotics .", "label": "", "metadata": {}, "score": "81.918396"}
{"text": "Colistin acts as a cationic detergent and interferes with the structure and function of the outer cytoplasmic membrane of bacteria .Colistin also has the ability to bind and neutralise bacterial endotoxins , released during infective exacerbations ( Li et al , 2005 ) .", "label": "", "metadata": {}, "score": "81.94316"}
{"text": "Bamford C , Bonorchis K , Ryan A , et al .Antimicrobial susceptibility patterns of selected bacteraemic isolates from South African public sector hospitals , 2010 .", "label": "", "metadata": {}, "score": "81.95261"}
{"text": "Bamford C , Bonorchis K , Ryan A , et al .Antimicrobial susceptibility patterns of selected bacteraemic isolates from South African public sector hospitals , 2010 .", "label": "", "metadata": {}, "score": "81.95261"}
{"text": "Bamford C , Bonorchis K , Ryan A , et al .Antimicrobial susceptibility patterns of selected bacteraemic isolates from South African public sector hospitals , 2010 .", "label": "", "metadata": {}, "score": "81.95261"}
{"text": "Numerous outbreaks and epidemics with these organisms have been reported , they have become endemic in several institutions , and increased mortality has been ascribed to them .", "label": "", "metadata": {}, "score": "81.96981"}
{"text": "Numerous outbreaks and epidemics with these organisms have been reported , they have become endemic in several institutions , and increased mortality has been ascribed to them .", "label": "", "metadata": {}, "score": "81.96981"}
{"text": "Numerous outbreaks and epidemics with these organisms have been reported , they have become endemic in several institutions , and increased mortality has been ascribed to them .", "label": "", "metadata": {}, "score": "81.96981"}
{"text": "Eradication of First or New Airway Colonization with P. aeruginosa .The effectiveness of the various antibioticregimes in eradicating early P. aeruginosa requires careful evaluation .", "label": "", "metadata": {}, "score": "82.06026"}
{"text": "PubMed ] .Mukhopadhyay S , Singh M , Cater JI , et al .Nebulised anti - Pseudomonal antibiotic therapy in cystic fibrosis : a meta - analysis of benefits and risks .", "label": "", "metadata": {}, "score": "82.08447"}
{"text": "These risk factors include : 3,9 .Similar to ESBLs , it also appears that long - term care facilities are reservoirs of KPCs because they act as a point of convergence of patients at high risk , amplified by cross - transmission , and this facilitates regional dissemination .", "label": "", "metadata": {}, "score": "82.12123"}
{"text": "These risk factors include : 3,9 .Similar to ESBLs , it also appears that long - term care facilities are reservoirs of KPCs because they act as a point of convergence of patients at high risk , amplified by cross - transmission , and this facilitates regional dissemination .", "label": "", "metadata": {}, "score": "82.12123"}
{"text": "These risk factors include : 3,9 .Similar to ESBLs , it also appears that long - term care facilities are reservoirs of KPCs because they act as a point of convergence of patients at high risk , amplified by cross - transmission , and this facilitates regional dissemination .", "label": "", "metadata": {}, "score": "82.12123"}
{"text": "Bronchial constriction .Airway reactivity occurs following the administration of all nebulised antibiotics and in some patients this may lead to the discontinuation of therapy .", "label": "", "metadata": {}, "score": "82.12225"}
{"text": "The low concentration of tigecycline in the urine further limits the use of this antimicrobial for the treatment of UTIs .Unless more compelling evidence of improved clinical outcomes in well - designed studies of high - dose tigecycline becomes available , tigecycline monotherapy is not routinely recommended for severe infections such as bacteremia or hospital - acquired pneumonia .", "label": "", "metadata": {}, "score": "82.13339"}
{"text": "178 - 181 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Galeva , M. W. Konstan , M. Higgins , G. Angyalosi , F. Brockhaus , S. Piggott , et al . , \" Tobramycin inhalation powder manufactured by improved process in cystic fibrosis : the randomized EDIT trial , \" Current Medical Research and Opinion , vol .", "label": "", "metadata": {}, "score": "82.15241"}
{"text": "The ELITE trial [ 42 ] included 88 subjects and used microbiological ( not clinical ) criteria as the primary outcome .The authors found that treatment with TIS for 28 days is an effective and well - tolerated therapy in CF .", "label": "", "metadata": {}, "score": "82.17587"}
{"text": "Clin Infect Dis 2013 , 56 : 697 - 700 .10.1093/cid / cis96923155147 View Article PubMed .Michalopoulos A , Virtzili S , Rafailidis P , Chalevelakis G , Damala M , Falagas ME : Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem - resistant Klebsiella pneumoniae in critically ill patients : a prospective evaluation .", "label": "", "metadata": {}, "score": "82.29939"}
{"text": "[PubMed ] .Catchpole CR , Andrews JM , Brenwald N , et al .A reassessment of the in - vitro activity of colistin sulphomethate sodium .", "label": "", "metadata": {}, "score": "82.351105"}
{"text": "It is currently undergoing phase 3 studies for complicated UTI and intra - abdominal infections [ 59 ] .Ceftaroline - avibactam , entering phase 3 trials , is similarly active against KPC - producing strains , but not against P. aeruginosa or other metallo - beta - lactamase - producing organisms .", "label": "", "metadata": {}, "score": "82.36026"}
{"text": "Patel N , Harrington S , Dihmess A , et al Clinical epidemiology of carbapenem - intermediate or -resistant Enterobacteriaceae .J Antimicrob Chemother 2011;66:1600 - 1608 .", "label": "", "metadata": {}, "score": "82.452286"}
{"text": "Patel N , Harrington S , Dihmess A , et al Clinical epidemiology of carbapenem - intermediate or -resistant Enterobacteriaceae .J Antimicrob Chemother 2011;66:1600 - 1608 .", "label": "", "metadata": {}, "score": "82.452286"}
{"text": "Patel N , Harrington S , Dihmess A , et al Clinical epidemiology of carbapenem - intermediate or -resistant Enterobacteriaceae .J Antimicrob Chemother 2011;66:1600 - 1608 .", "label": "", "metadata": {}, "score": "82.452286"}
{"text": "Clin Infect Dis .Coelho JM , Turton JF , Kaufmann ME , et al .Occurrence of carbapenem - resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England .", "label": "", "metadata": {}, "score": "82.591805"}
{"text": "3018 - 3020 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Woodford , P. M. Tierno Jr. , K. Young et al . , \" Outbreak of Klebsiella pneumoniae producing a new carbapenem - hydrolyzing class A \u03b2 -lactamase , KPC-3 , in a New York Medical Center , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "82.62134"}
{"text": "The Role of Inhaled Antibiotics .A Cochrane review studied the role of inhaled antibiotics for long - term suppression of chronic P. aeruginosa infection [ 57 ] .", "label": "", "metadata": {}, "score": "82.64263"}
{"text": "As it can be seen from the table , early chronic suppressive treatment of S. aureus has been associated with an increased infection with P. aeruginosa without any major clinical benefits .", "label": "", "metadata": {}, "score": "82.64322"}
{"text": "6 , pp .841 - 849 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Proesmans , F. Vermeulen , L. Boulanger , J. Verhaegen , and K. De Boeck , \" Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis , \" Journal of Cystic fibrosis , vol .", "label": "", "metadata": {}, "score": "82.67254"}
{"text": "Especially for Gram - negative infections , there are no new drugs in the pipeline .It really is time to pay attention to this , before we find ourselves at the point where no drugs work at all .", "label": "", "metadata": {}, "score": "82.71821"}
{"text": "The IV formulation ( fosfomycin disodium ) is not available in the US and other countries , although it has been used successfully in Greece , mostly as an adjuvant drug in combination therapies [ 57 ] .", "label": "", "metadata": {}, "score": "82.801254"}
{"text": "All tested isolates were susceptible to minocycline .For 5 of the patients , minocycline was the only active agent used to treat their MDR - ABC infection .", "label": "", "metadata": {}, "score": "82.82413"}
{"text": "The paucity of novel antimicrobials in development escalates the antimicrobial resistance problem , severely reducing the available therapeutic choices .In this review , we will summarize the main treatment options used in clinical practice as well as the few antimicrobials currently in development .", "label": "", "metadata": {}, "score": "82.88037"}
{"text": "17 , pp .1707 - 1715 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .V. A. Loening - Baucke , E. Mischler , and M. G. Myers , \" A placebo - controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis , \" Journal of Pediatrics , vol .", "label": "", "metadata": {}, "score": "82.880844"}
{"text": "384 - 391 , 2013 .View at Google Scholar .S. Besier , C. Smaczny , C. Von Mallinckrodt et al . , \" Prevalence and clinical significance of Staphylococcus aureus small - colony variants in cystic fibrosis lung disease , \" Journal of Clinical Microbiology , vol .", "label": "", "metadata": {}, "score": "82.93669"}
{"text": "690 - 703 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. M\u00e1iz , R. M. Gir\u00f3n , C. Olveira et al . , \" Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis : systematic review of randomised controlled trials , \" Expert Opinion on Pharmacotherapy , vol .", "label": "", "metadata": {}, "score": "82.95434"}
{"text": "Because so few agents are available to treat the present population of XDR organisms , it is extremely difficult to study restrictive formulary interventions , and if they were employed they would be unlikely to be successful .", "label": "", "metadata": {}, "score": "83.03376"}
{"text": "Because so few agents are available to treat the present population of XDR organisms , it is extremely difficult to study restrictive formulary interventions , and if they were employed they would be unlikely to be successful .", "label": "", "metadata": {}, "score": "83.03376"}
{"text": "Because so few agents are available to treat the present population of XDR organisms , it is extremely difficult to study restrictive formulary interventions , and if they were employed they would be unlikely to be successful .", "label": "", "metadata": {}, "score": "83.03376"}
{"text": "10.4103/0972 - 5229.56048 PubMed Central PubMed View Article .Li J , Nation RL , Turnidge JD , Milne RW , Coulthard K , Rayner CR , Paterson DL : Colistin : the re - emerging antibiotic for multidrug - resistant Gram - negative bacterial infections .", "label": "", "metadata": {}, "score": "83.04822"}
{"text": "Most patients treated with tigecycline in this cohort had an MIC of 2 \u03bcg / mL ( which is the cutoff for susceptibility ) and severe infections with high Acute Physiology and Chronic Health Evaluation II scores , which may explain why tigecycline was ineffective [ 46 ] .", "label": "", "metadata": {}, "score": "83.069885"}
{"text": "4 , pp .N75-N81 , 2001 .View at Google Scholar \u00b7 View at Scopus .P. Giakkoupi , A. Xanthaki , M. Kanelopoulo et al . , \" VIM-1 metallo- \u03b2 -lactamase - producing Klebsiella pneumoniae strains in Greek hospitals , \" Journal of Clinical Microbiology , vol .", "label": "", "metadata": {}, "score": "83.08598"}
{"text": "165 - 169 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. S\u00e1nchez - Romero , \u00c1. Asensio , J. Oteo et al . , \" Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15 : molecular basis , clinical risk factors , and outcome , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "83.17042"}
{"text": "12 , no .6 , pp .662 - 666 , 2013 .View at Publisher \u00b7 View at Google Scholar .S. C. L. Hewer and A. R. Smyth , \" Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis , \" Cochrane Database of Systematic Reviews , vol .", "label": "", "metadata": {}, "score": "83.19372"}
{"text": "Clin Ther 2012 , 34 : 1314 - 1323 .10.1016/j.clinthera.2012.05.00222691610 View Article PubMed .Satlin MJ , Kubin CJ , Blumenthal JS , Cohen AB , Furuya EY , Wilson SJ , Jenkins SG , Calfee DP : Comparative effectiveness of aminoglycosides , polymyxin B , and tigecycline for clearance of carbapenem - resistant Klebsiella pneumoniae from urine .", "label": "", "metadata": {}, "score": "83.22812"}
{"text": "Increased availability of new inhaled antibiotics should also allow comparative trials to be performed between them .Though , assessment of pulmonary function ( FEV1 ) is the common end point in many trials , quality of life ( symptom score , medication score , and level of bother ) should also bemeasured .", "label": "", "metadata": {}, "score": "83.25111"}
{"text": "6 , pp .831 - 838 , 1987 .View at Google Scholar \u00b7 View at Scopus . A. J. Day , J. Williams , C. McKeown , A. Bruton , and P. H. Weller , \" Evaluation of inhaled colomycin in children with cystic Fibrosis , \" in Proceedings of the 10th International Cystic fibrosis Congress , 1988 .", "label": "", "metadata": {}, "score": "83.47725"}
{"text": "99 - 103 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Vazquez , M. Municio , M. Corera , L. Gaztelurrutia , A. Sojo , and J. C. Vitoria , \" Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis , \" Acta Paediatrica , International Journal of Paediatrics , vol .", "label": "", "metadata": {}, "score": "83.4862"}
{"text": "Dudhani RV , Turnidge JD , Nation RL , Li J : fAUC / MIC is the most predictive pharmacokinetic / pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models .", "label": "", "metadata": {}, "score": "83.51393"}
{"text": "Antibiotics administered via parenteral , inhaled , and oral routes are efficacious ; however , the optimal regimen and duration of therapy remain unclear .Inhaled antibiotics are an attractive option , delivering high concentrations of antibiotic directly to the infection site while minimizing systemic exposure .", "label": "", "metadata": {}, "score": "83.51407"}
{"text": "10.1128/JCM.02466 - 08268184919261795 View Article PubMed Central PubMed .Daikos GL , Markogiannakis A : Carbapenemase - producing Klebsiella pneumoniae : ( when ) might we still consider treating with carbapenems ?", "label": "", "metadata": {}, "score": "83.5271"}
{"text": "921 - 928 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Z. Retsch - Bogart , J. L. Burns , K. L. Otto et al . , \" A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "83.5325"}
{"text": "212 - 216 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Equi , I. M. Balfour - Lynn , A. Bush , and M. Rosenthal , \" Long term azithromycin in children with cystic fibrosis : a randomised , placebo - controlled crossover trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "83.58455"}
{"text": "[PubMed ] .Valerius NH , Koch C , Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment .Lancet 1991 ; 338:725 - 726 .", "label": "", "metadata": {}, "score": "83.614716"}
{"text": "The successful use of minocycline in treating multidrug - resistant Acinetobacter baumannii pneumonia has been reported in the literature , but to our knowledge , ours is the first report regarding the use of minocycline for traumatic wound infections caused by this pathogen .", "label": "", "metadata": {}, "score": "83.64884"}
{"text": "Although hepatic disease is unlikely to alter the elimination of colistin , no information is available .Breast feeding .5 % of serum level ends up in breast milk .", "label": "", "metadata": {}, "score": "83.66603"}
{"text": "10 , pp .895 - 902 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Steinkamp , S. Schmitt - Grohe , G. D\u00f6ring et al . , \" Once - weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection , \" Respiratory Medicine , vol .", "label": "", "metadata": {}, "score": "83.670364"}
{"text": "The emergence of MDR Gram - negative infection requires treatment with an old antibiotic such as colistin , but the use of colistin may promote the selection of \" super bugs \" such as KPRC .", "label": "", "metadata": {}, "score": "83.69174"}
{"text": "9338 , pp .978 - 984 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . L. Saiman , B. C. Marshall , N. Mayer - Hamblett et al . , \" Azithromycin in patients with cystic fibrosis chronically Infected with Pseudomonas aeruginosa : a randomized controlled trial , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "83.70716"}
{"text": "Minocycline has potential as a safe oral therapy .Its activity against Acinetobacter species both in vitro and in vivo has been known for many years , and it has been used clinically with success . 8 - 10 Based on these data , our institution has begun to use minocycline in some patients with MDR - ABC infections .", "label": "", "metadata": {}, "score": "83.809975"}
{"text": "984 - 989 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. J. Wolter , J. C. Emerson , S. McNamara , A. M. Buccat , X. Qin , E. Cochrane , et al . , \" Staphylococcus aureus small - colony variants are independently associated with worse lung disease in children with cystic fibrosis , \" Clinical Infectious Diseases , vol .", "label": "", "metadata": {}, "score": "83.81319"}
{"text": "308 - 309 , 1993 .View at Google Scholar \u00b7 View at Scopus .G. Steinkamp , B. Tummler , R. Malottke , and H. Von der Hardt , \" Treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis , \" Archives of Disease in Childhood , vol .", "label": "", "metadata": {}, "score": "83.89138"}
{"text": "Blood stream infection and catheter associated urinary tract infection were defined according to Center of Disease Control ( CDC ) criteria [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "83.89714"}
{"text": "1022 - 1028 , 1989 .View at Google Scholar \u00b7 View at Scopus . A. Munck , S. Bonacorsi , P. Mariani - Kurkdjian et al . , \" Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "83.92552"}
{"text": "Limitations .A number of limitations apply to all the trials ( mostly RCTs ) included in this overview .First , most of the trials included relatively small numbers of patients , which lack of adequate power to prove the hypothesis ( outcome measures ) .", "label": "", "metadata": {}, "score": "83.957664"}
{"text": "[PubMed ] .Littlewood JM , Miller MG , Ghoneim AT , et al .Nebulised colomycin for early Pseudomonal colonisation in cystic fibrosis .", "label": "", "metadata": {}, "score": "83.95781"}
{"text": "The ideal dose for colistin in the treatment of severe CRE infections is uncertain .In addition , significant confusion may arise because of differences in formulations between the intravenous ( IV ) product available in the US ( colistin - based ) and the one available in Europe and other regions ( colistimethate sodium ) ( Table 2 ) .", "label": "", "metadata": {}, "score": "83.962234"}
{"text": "Clin Infect Dis 2012 , 54 : 1727 - 1729 .10.1093/cid / cis31122423122 View Article PubMed .Zarkotou O , Pournaras S , Tselioti P , Dragoumanos V , Pitiriga V , Ranellou K , Prekates A , Themeli - Digalaki K , Tsakris A : Predictors of mortality in patients with bloodstream infections caused by KPC - producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment .", "label": "", "metadata": {}, "score": "83.96693"}
{"text": "10.1016/j.ijantimicag.2009.08.01319828298 View Article PubMed .Michalopoulos AS , Livaditis IG , Gougoutas V : The revival of fosfomycin .Int J Infect Dis 2011 , 15 : e732-e739 .", "label": "", "metadata": {}, "score": "83.9765"}
{"text": "8256 , pp .1137 - 1139 , 1981 .View at Google Scholar \u00b7 View at Scopus .P. Kun , L. I. Landau , and P. D. Phelan , \" Nebulized gentamicin in children and adolescents with cystic fibrosis , \" Australian Paediatric Journal , vol .", "label": "", "metadata": {}, "score": "84.19713"}
{"text": "[PubMed ] .Hoiby N , Frederiksen B , Pressler T. Eradication of early Pseudomonas aeruginosa infection .J Cyst Fibros 2005 ; 4 : 49 - 54 .", "label": "", "metadata": {}, "score": "84.2021"}
{"text": "106 - 111 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Jensen , S. S. Pedersen , C. H. Nielsen , N. Hoiby , and C. Koch , \" The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "84.35157"}
{"text": "[PubMed ] .Koyama Y , Kurosawa A , Tsuchiya A , et al .A new antibiotic , colistin , produced by spore - forming soil bacteria .", "label": "", "metadata": {}, "score": "84.35158"}
{"text": "Trials only reporting microbiological parameters were excluded .In case there was no RCT for an important outcome , we considered observational studies if available .", "label": "", "metadata": {}, "score": "84.35977"}
{"text": "10.1093/jac / dkm511 PubMed View Article .Bergen PJ , Bulitta JB , Forrest A , Tsuji BT , Li J , Nation RL : Pharmacokinetic ( PK)/Pharmacodynamic ( PD ) investigation of colistin ( C ) against Pseudomonas aeruginosa ( Pa ) using an in vitro model .", "label": "", "metadata": {}, "score": "84.374344"}
{"text": "10.1093/jac / dkl512 PubMed View Article .Poudyal A , Howden BP , Bell JM , Gao W , Owen RJ , Turnidge JD , Nation RL , Li J : In vitro pharmacodynamics of colistin against multidrug - resistant Klebsiella pneumoniae .", "label": "", "metadata": {}, "score": "84.41916"}
{"text": "MA wrote the first draft of the manuscript .MEF did substantial revisions .Both authors approved the final version of the manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "84.44498"}
{"text": "4 , p. 239 , 1999 .View at Google Scholar \u00b7 View at Scopus .I. Stelmach , A. Korzeniewska , and W. Stelmach , \" Long - term benefits of inhaled tobramycin in children with cystic fibrosis : first clinical observations from Poland , \" Respiration , vol .", "label": "", "metadata": {}, "score": "84.49989"}
{"text": "1135 - 1149 , 2013 .View at Google Scholar Treatment for infections with carbapenem - resistant Enterobacteriaceae : what options do we still have ?", "label": "", "metadata": {}, "score": "84.60387"}
{"text": "272 - 279 , 1987 .View at Google Scholar \u00b7 View at Scopus .C. D. Sheldon , B. K. Assoufi , and M. E. Hodson , \" Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa , \" Respiratory Medicine , vol .", "label": "", "metadata": {}, "score": "84.61675"}
{"text": "[PubMed ] .Frederiksen B , Koch C , Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis .", "label": "", "metadata": {}, "score": "84.668"}
{"text": "Polymyxin B differs from colistin by one amino acid [ 27 ] .In contrast to colistin , however , it is administered as its active form and thus achieves higher plasma concentrations faster , making the need for a loading dose less stringent [ 16 ] .", "label": "", "metadata": {}, "score": "84.681015"}
{"text": "Discussion .Key Findings .P. aeruginosa colonisation has a negative effect on lung function in patients with cystic fibrosis ( CF ) .It is rather easy to eradicate the organism in the early stage of colonisation and to maintain a reduced bacterial density during chronic colonisation .", "label": "", "metadata": {}, "score": "84.69098"}
{"text": "Other devices are available which have perforated oscillating membranes that create the mist for inhalation .This technology creates a more uniform particle size within the respirable therapeutic range .", "label": "", "metadata": {}, "score": "84.756256"}
{"text": "610 - 623 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. M. Treggiari , G. Retsch - Bogart , N. Mayer - Hamblett et al . , \" Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis , \" Archives of Pediatrics and Adolescent Medicine , vol .", "label": "", "metadata": {}, "score": "84.786674"}
{"text": "In another crossover study , the authors included 33 participants of 7.8 - 16 years age , and administered gentamicin ( 20 mg ) BID for 12 months [ 64 ] .", "label": "", "metadata": {}, "score": "84.832466"}
{"text": "Other adverse reactions to colistin - general - Dizziness - Confusion - Visual disturbance - Numbness , facial paraesthesia - Vertigo - Vasomotor instability - Slurred speech - Psychosis - Hypersensitivity - Local irritation - Apnoea .", "label": "", "metadata": {}, "score": "84.84091"}
{"text": "168 - 172 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Szaff and N. Hoiby , \" Antibiotic treatment of Staphyloccus aureus infection in cystic fibrosis , \" Acta Paediatrica Scandinavica , vol .", "label": "", "metadata": {}, "score": "84.8506"}
{"text": "ERCP , endoscopic retrograde cholangiopancreatography ; KPC , Klebsiella pneumoniae carbapenemase ; NDM , New Delhi metallo - beta - lactamase ; OXA , oxacillin - hydrolyzing .", "label": "", "metadata": {}, "score": "84.99529"}
{"text": "Nebulised dose .Children less than two years - one Mega unit colistin twice daily .Children over two years of age and standard adult dose - two Mega unit colistin twice daily .", "label": "", "metadata": {}, "score": "85.00868"}
{"text": "Although sputum drug concentrations decreased after a peak at 1 h , the mean colistin concentrations remained above 4 mg / L after 12 h. Serum concentrations of colistin reached their maximum at 1.5 h after inhalation and decreased thereafter .", "label": "", "metadata": {}, "score": "85.02324"}
{"text": "In contrast to infections from other organisms such as Staphylococcus aureus , MDR - ABC wound infections in our institution are usually cured with a single course of an active antimicrobial and are not likely to relapse .", "label": "", "metadata": {}, "score": "85.05252"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. L. Daikos , E. Vryonis , M. Psichogiou et al . , \" Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo- \u03b2 -lactamase , \" Journal of Antimicrobial Chemotherapy , vol .", "label": "", "metadata": {}, "score": "85.14261"}
{"text": "10.1007/s10096 - 013 - 1870 - 423553594 View Article PubMed .Kontopidou F , Giamarellou H , Katerelos P , Maragos A , Kioumis I , Trikka - Graphakos E , Valakis C , Maltezou HC : Infections caused by carbapenem - resistant Klebsiella pneumoniae among patients in intensive care units in Greece : a multi - centre study on clinical outcome and therapeutic options .", "label": "", "metadata": {}, "score": "85.15425"}
{"text": "The PK / PD relationship of colistin against P. aeruginosa has been examined recently in a vitro model .A significant finding of the study was that colistin efficacy against P. aeruginosa was best correlated with the AUC : MIC ratio of total and unbound colistin rather than the Cmax / MIC ratio .", "label": "", "metadata": {}, "score": "85.235016"}
{"text": "10.1007/s00431 - 009 - 1137 - 3 PubMed View Article .Celebi S , Hacimustafaoglu M , Koksal N , Ozkan H , Cetinkaya M : Colistimethate sodium therapy for multidrug - resistant isolates in pediatric patients .", "label": "", "metadata": {}, "score": "85.26454"}
{"text": "10.1093/jac / dki461 PubMed View Article .Lu Q , Girardi C , Zhang M , Bouhemad B , Louchahi K , Petitjean O , Wallet F , Becquemin MH , Le Naour G , Marquette CH , Rouby JJ : Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa .", "label": "", "metadata": {}, "score": "85.33336"}
{"text": "In a cohort study [ 40 ] , 15 patients ( mean age 9 years ) inhaled 80 mg tobramycin twice daily ( BID ) for 12 months .", "label": "", "metadata": {}, "score": "85.51929"}
{"text": "As we have already discussed , there are many therapeutic options for both MSSA and MRSA .But many questions remain regarding the clinical utility and tradeoffs of prophylactic therapy for MSSA and eradication and treatment for MRSA .", "label": "", "metadata": {}, "score": "85.53982"}
{"text": "10.1016/S1473 - 3099(06)70580 - 1 PubMed View Article .Owen RJ , Li J , Nation RL , Spelman D : In vitro pharmaco - dynamics of colistin against Acinetobacter baumannii clinical isolates .", "label": "", "metadata": {}, "score": "85.54978"}
{"text": "In all the latest bad news about bacteria becoming highly resistant - through carbapenem resistance , or the \" Indian supergene \" NDM-1 - there has been one hopeful thread : All of the organisms have remained susceptible to one very old , little - used drug called colistin .", "label": "", "metadata": {}, "score": "85.58055"}
{"text": "420 - 427 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S.-W. Liu , H.-J. Chang , J.-H. Chia , A.-J. Kuo , T.-L. Wu , and M.-H. Lee , \" Outcomes and characteristics of ertapenem - nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan : a matched case - control study , \" Journal of Microbiology , Immunology and Infection , vol .", "label": "", "metadata": {}, "score": "85.60876"}
{"text": "PubMed ] .Hodson ME , Penketh ARL , Batten JC .Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa in patients with cystic fibrosis .", "label": "", "metadata": {}, "score": "85.679504"}
{"text": "Current treatment options for infections with carbapenem - resistant Enterobacteriaceae .The optimal treatment of infections with CRE is uncertain , as most data come from retrospective case series and anecdotal case reports ; few prospective studies or randomized controlled trials are published on this topic .", "label": "", "metadata": {}, "score": "85.714745"}
{"text": "We could identify one study [ 45 ] .This cohort study including very few patents ( . ) with recent P. aeruginosa positive cultures used inhaled Colomycin 500,000 U BID and found a 36 % reduction in the culture rate in long term .", "label": "", "metadata": {}, "score": "85.714905"}
{"text": "J Clin Microbiol 2010;48:2271 - 2274 .Brink AJ , Botha RF , Poswa X , et al Antimicrobial susceptibility of Gram - negative pathogens isolated from patients with complicated intra - abdominal infections in South African hospitals ( SMART Study 2004 - 2009 ) : Impact of the new carbapenem breakpoints .", "label": "", "metadata": {}, "score": "85.76606"}
{"text": "J Clin Microbiol 2010;48:2271 - 2274 .Brink AJ , Botha RF , Poswa X , et al Antimicrobial susceptibility of Gram - negative pathogens isolated from patients with complicated intra - abdominal infections in South African hospitals ( SMART Study 2004 - 2009 ) : Impact of the new carbapenem breakpoints .", "label": "", "metadata": {}, "score": "85.76606"}
{"text": "J Clin Microbiol 2010;48:2271 - 2274 .Brink AJ , Botha RF , Poswa X , et al Antimicrobial susceptibility of Gram - negative pathogens isolated from patients with complicated intra - abdominal infections in South African hospitals ( SMART Study 2004 - 2009 ) : Impact of the new carbapenem breakpoints .", "label": "", "metadata": {}, "score": "85.76606"}
{"text": "We aim to include randomized trials ( RCTS ) mainly , but if we find no RCT for any of the outcome , we will discuss the observational studies .", "label": "", "metadata": {}, "score": "85.803375"}
{"text": "587 - 593 , 1993 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . U.B. Schaad , J. Wedgwood , A. Ruedeberg , R. Kraemer , and B. Hampel , \" Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis , \" Pediatric Infectious Disease Journal , vol .", "label": "", "metadata": {}, "score": "85.808044"}
{"text": "29 - 34 , 2013 .View at Google Scholar .F. Ratjen , G. Doring , and W. H. Nikolaizik , \" Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "85.826866"}
{"text": "To maximize the AUC : MIC ratio , higher doses of colistimethate sodium and alterations in the dosing intervals may be warranted in the ICU setting .", "label": "", "metadata": {}, "score": "85.84479"}
{"text": "How this will be implemented in South Africa remains unclear .Management of invasive devices .CRE have been identified from device - associated infections , particularly catheter - associated urinary tract infections .", "label": "", "metadata": {}, "score": "85.90421"}
{"text": "How this will be implemented in South Africa remains unclear .Management of invasive devices .CRE have been identified from device - associated infections , particularly catheter - associated urinary tract infections .", "label": "", "metadata": {}, "score": "85.90421"}
{"text": "How this will be implemented in South Africa remains unclear .Management of invasive devices .CRE have been identified from device - associated infections , particularly catheter - associated urinary tract infections .", "label": "", "metadata": {}, "score": "85.90421"}
{"text": "10.1128/AAC.00387 - 11323275021968368 View Article PubMed Central PubMed .Bulik CC , Nicolau DP : Double - carbapenem therapy for carbapenemase - producing Klebsiella pneumoniae .", "label": "", "metadata": {}, "score": "85.907135"}
{"text": "Antimicrobials in development .Several parenteral antimicrobial therapies are currently under investigation for the treatment of multidrug - resistant Gram - negative infections , including CRE .", "label": "", "metadata": {}, "score": "85.97553"}
{"text": "128 - 140 , 1988 .View at Google Scholar \u00b7 View at Scopus .M. E. Falagas , P. K. Koletsi , and I. A. Bliziotis , \" The diversity of definitions of multidrug - resistant ( MDR ) and pandrug - resistant ( PDR ) Acinetobacter baumannii and Pseudomonas aeruginosa , \" Journal of Medical Microbiology , vol .", "label": "", "metadata": {}, "score": "85.98088"}
{"text": "10.1186/1476 - 0711 - 11 - 32355298723234297 View Article PubMed Central PubMed .Lee YT , Tsao SM , Hsueh PR : Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare - associated multidrug - resistant Acinetobacter baumannii infections .", "label": "", "metadata": {}, "score": "85.99904"}
{"text": "5 , pp .330 - 335 , 1997 .View at Google Scholar .C. R. Hansen , T. Pressler , and N. H\u00f8iby , \" Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : 15 years experience , \" Journal of Cystic Fibrosis , vol .", "label": "", "metadata": {}, "score": "86.00015"}
{"text": "10.1016/j.ijantimicag.2009.11.016 PubMed View Article .Koomanachai P , Tiengrim S , Kiratisin P , Thamlikitkul V : Efficacy and safety of colistin ( colistimethate sodium ) for therapy of infections caused by multidrug - resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital , Bangkok , Thailand .", "label": "", "metadata": {}, "score": "86.02014"}
{"text": "Mean relative changes after 1 course ( AZLI : 8.35 % ; TNS : 0.55 % ; .Tobramycin Inhaled versus Placebo .Fosfomycin / Tobramycin versus Placebo .", "label": "", "metadata": {}, "score": "86.06921"}
{"text": "Colistin is approximately 50 % bound to human plasma .Peak serum levels after intravenous ( i.v . ) administration are achieved within 10 min .", "label": "", "metadata": {}, "score": "86.11505"}
{"text": "Colistin also has activity against a number of clinically important organisms such as Acinetobacter species , Citrobacter , Escherichia coli , Enterobacter species , Haemophilus influenzae , Klebsiella species , Salmonella species and Shigella species ( Catchpole et al , 1997 ) .", "label": "", "metadata": {}, "score": "86.14499"}
{"text": "142 - 146 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. J. Lai , Y. Cheng , and P. M. Farrell , \" The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening : evidence from the United States cystic fibrosis Foundation Registry data , \" Journal of Pediatrics , vol .", "label": "", "metadata": {}, "score": "86.25113"}
{"text": "Measurements of chest tightness , using a visual analogue scale ( VAS ) , and FEV 1 were recorded before and 0 , 15 , 30 , 60 , and 90 minutes following inhalation .", "label": "", "metadata": {}, "score": "86.27555"}
{"text": "In a 2-year cohort study of 100 children with CF , small - colony variants ( SCVs ) of S. aureus were detected among 24 % of participants and were significantly associated with a greater drop in lung function during the study [ 76 ] .", "label": "", "metadata": {}, "score": "86.32851"}
{"text": "10.1093/jac / dkn425 PubMed View Article .Li J , Rayner CR , Nation RL , Owen RJ , Spelman D , Tan KE , Liolios L : Hetero - resistance to colistin in multidrug - resistant Acinetobacter baumannii .", "label": "", "metadata": {}, "score": "86.371"}
{"text": "Brannon MK , Pier M , Stevens L , et al .Colistin treated cystic fibrosis patients harbor polymyxin - resistant strains of Pseudomonas aeruginosa some with mutation of PMRAB , a two - component regulator of lipid structure .", "label": "", "metadata": {}, "score": "86.3757"}
{"text": "S57-S63 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Goerke , K. Kraning , M. Stern , G. D\u00f6ring , K. Botzenhart , and C. Wolz , \" Molecular epidemiology of community - acquired Staphylococcus aureus in families with and without cystic fibrosis patients , \" Journal of Infectious Diseases , vol .", "label": "", "metadata": {}, "score": "86.38219"}
{"text": "10.1016/j.diagmicrobio.2010.10.02021251571 View Article PubMed .Guner R , Hasanoglu I , Keske S , Kalem AK , Tasyaran MA : Outcomes in patients infected with carbapenem - resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy .", "label": "", "metadata": {}, "score": "86.38548"}
{"text": "[PubMed ] .Day AJ , Williams J , Mckeown C , et a l. Evaluation of inhaled colomycin in children with cystic fibrosis . 10th International Cystic Fibrosis Congress , Sydney , Australia .", "label": "", "metadata": {}, "score": "86.443085"}
{"text": "53 , no . 3 , pp . 1 - 36 , 2004 .View at Google Scholar \u00b7 View at Scopus .G. Patel , S. Huprikar , S. H. Factor , S. G. Jenkins , and D. P. Calfee , \" Outcomes of carbapenem - resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies , \" Infection Control and Hospital Epidemiology , vol .", "label": "", "metadata": {}, "score": "86.45755"}
{"text": "Patients and Methods .This prospective cohort study was conducted in a 12-bed ICU in the University Hospital of Larissa , Thessaly , during a 12-month period , between 2011 and 2012 .", "label": "", "metadata": {}, "score": "86.46096"}
{"text": "The significance of chronic P. aeruginosa infection in CF has lead to developments in strategies to prevent or delay progression from initial acquisition of P. aeruginosa to chronic infection .", "label": "", "metadata": {}, "score": "86.47746"}
{"text": "In this report , we describe the use of minocycline in treating traumatic wound infections caused by MDR - ABC .Minocycline was successfully used in 7 of the 8 patients .", "label": "", "metadata": {}, "score": "86.49724"}
{"text": "421 - 425 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. G. Kwak , S.-H. Choi , E. J. Choo et al . , \" Risk factors for the acquisition of carbapenem - resistant Klebsiella pneumoniae among hospitalized patients , \" Microbial Drug Resistance , vol .", "label": "", "metadata": {}, "score": "86.52925"}
{"text": "There have been other scattered reports of colistin resistance : One in Hungary , two in Greece , one in Korea - all reported last year - and a cluster of five cases in Detroit in 2009 .", "label": "", "metadata": {}, "score": "86.5936"}
{"text": "The dosage of colistin ( base ) for intraventricular administration ranges from 5 mg to 20 mg per day ( divided in 1 or 2 doses ) .", "label": "", "metadata": {}, "score": "86.96623"}
{"text": "Individuals with cystic fibrosis ( CF ) whose respiratory tract is colonized with P. aeruginosa have as a group increased pulmonary disease , a more rapid decline in pulmonary function and a decreased survival to adulthood .", "label": "", "metadata": {}, "score": "86.98579"}
{"text": "Notably , minocycline often maintains activity against MDR - ABC isolates that are resistant to imipenem . 9Although not free of adverse effects , it has a long historical record of safety and is clearly less toxic than colistin .", "label": "", "metadata": {}, "score": "86.99302"}
{"text": "10.1016/j.jhin.2010.03.02120705205 View Article PubMed .Landman D , Georgescu C , Martin DA , Quale J : Polymyxins revisited .Clin Microbiol Rev 2008 , 21 : 449 - 465 .", "label": "", "metadata": {}, "score": "87.0347"}
{"text": "10.1080/00365540903147001 PubMed View Article .Cheng CY , Sheng WH , Wang JT , Chen YC , Chang SC : Safety and efficacy of intravenous colistin ( colistin methanesulphonate ) for severe multidrug - resistant Gram - negative bacterial infections .", "label": "", "metadata": {}, "score": "87.08967"}
{"text": "Minocycline Therapy for Traumatic Wound Infections Caused by the Multidrug - Resistant Acinetobacter baumannii - Acinetobacter calcoaceticus Complex .Author Information .The authors are employees of the US government , and this work was performed as part of their official duties .", "label": "", "metadata": {}, "score": "87.09294"}
{"text": "Shelf life .Colistin ( Colomycin ) comes as a sterile powder for solution .It has a shelf life of three years and once in solutions it remains stable for 28 days at 4 0 C. Following reconstitution with sterile water , the solution should be used within seven days ( Li et al , 2001 ) .", "label": "", "metadata": {}, "score": "87.23888"}
{"text": "Detection and treatment options for Klebsiella pneumonia carbapenemases ( KPCs ) : an emerging cause of multidrug - resistant infection .J Antimicrob Chemother 2010;65:1119 - 1125 .", "label": "", "metadata": {}, "score": "87.2418"}
{"text": "Detection and treatment options for Klebsiella pneumonia carbapenemases ( KPCs ) : an emerging cause of multidrug - resistant infection .J Antimicrob Chemother 2010;65:1119 - 1125 .", "label": "", "metadata": {}, "score": "87.2418"}
{"text": "Detection and treatment options for Klebsiella pneumonia carbapenemases ( KPCs ) : an emerging cause of multidrug - resistant infection .J Antimicrob Chemother 2010;65:1119 - 1125 .", "label": "", "metadata": {}, "score": "87.2418"}
{"text": "It is known that CMS and colistin ( base ) PKs differ , given that they have different structures , antibacterial activity , and toxicity .", "label": "", "metadata": {}, "score": "87.31413"}
{"text": "Azithromycin Compared to Placebo or Other Antibiotics .Parenteral Antibiotics Compared .Six children with P. aeruginosa isolated from their respiratory tract completed a randomized crossover study of oral flucloxacillin and nebulized aminoglycoside versus placebo [ 71 ] .", "label": "", "metadata": {}, "score": "87.353745"}
{"text": "10.1093/jac / dkl32716895936 View Article PubMed .Livermore DM , Warner M , Mushtaq S , Doumith M , Zhang J , Woodford N : What remains against carbapenem - resistant Enterobacteriaceae ?", "label": "", "metadata": {}, "score": "87.43481"}
{"text": "10.1016/j.ijid.2006.09.011 PubMed View Article .Kim J , Lee KH , Yoo S , Pai H : Clinical characteristics and risk factors of colistin - induced nephrotoxicity .", "label": "", "metadata": {}, "score": "87.43825"}
{"text": "12 , pp .4793 - 4799 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Bratu , D. Landman , R. Haag et al . , \" Rapid spread of carbapenem - resistant Klebsiella pneumoniae in New York City : a new threat to our antibiotic armamentarium , \" Archives of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "87.49075"}
{"text": "This safe and inexpensive drug would be an important addition to the scant armamentarium of available agents .Minocycline has several characteristics that make it a rational alternative to the other agents often used to treat MDR Acinetobacter wound infections .", "label": "", "metadata": {}, "score": "87.6897"}
{"text": "12 , pp .1099 - 1106 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. Hussein , H. Sprecher , T. Mashiach , I. Oren , I. Kassis , and R. Finkelstein , \" Carbapenem resistance among Klebsiella pneumoniae isolates : risk factors , molecular characteristics , and susceptibility patterns , \" Infection Control and Hospital Epidemiology , vol .", "label": "", "metadata": {}, "score": "87.69182"}
{"text": "Won SY , Munoz - Price LS , Lolans K , et al Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase - producing Enterobacteriaceae .", "label": "", "metadata": {}, "score": "87.73642"}
{"text": "Won SY , Munoz - Price LS , Lolans K , et al Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase - producing Enterobacteriaceae .", "label": "", "metadata": {}, "score": "87.73642"}
{"text": "Won SY , Munoz - Price LS , Lolans K , et al Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase - producing Enterobacteriaceae .", "label": "", "metadata": {}, "score": "87.73642"}
{"text": "Crit Care Med 2008;36:2433 - 2440 .[Links ] .Imberti R , Cusato M , Villani P , et al .Steady state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration .", "label": "", "metadata": {}, "score": "87.820694"}
{"text": "Crit Care Med 2008;36:2433 - 2440 .[Links ] .Imberti R , Cusato M , Villani P , et al .Steady state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration .", "label": "", "metadata": {}, "score": "87.820694"}
{"text": "Crit Care Med 2008;36:2433 - 2440 .[Links ] .Imberti R , Cusato M , Villani P , et al .Steady state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration .", "label": "", "metadata": {}, "score": "87.820694"}
{"text": "[Links ] .Best Care ...Always ![Links ] Indicadores .Links relacionados .Compartilhar .SAMJ , S. Afr . med .", "label": "", "metadata": {}, "score": "87.8652"}
{"text": "View at Google Scholar \u00b7 View at Scopus .B. M. Assael , T. Pressler , D. Bilton , M. Fayon , R. Fischer , R. Chiron , et al . , \" Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis : a comparative efficacy trial , \" Journal of Cystic fibrosis , vol .", "label": "", "metadata": {}, "score": "88.014725"}
{"text": "1749 - 1756 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Clement , A. Tamalet , E. Leroux , S. Ravilly , B. Fauroux , and J.-P. Jais , \" Long term effects of azithromycin in patients with cystic fibrosis : a double blind , placebo controlled trial , \" Thorax , vol .", "label": "", "metadata": {}, "score": "88.02715"}
{"text": "Other authors : no disclosure .References .Brink AJ , Feldman C , Richards GA , et al Emergence of extensive drug resistance ( XDR ) among Gram - negative bacilli in South Africa looms nearer .", "label": "", "metadata": {}, "score": "88.14661"}
{"text": "Other authors : no disclosure .References .Brink AJ , Feldman C , Richards GA , et al Emergence of extensive drug resistance ( XDR ) among Gram - negative bacilli in South Africa looms nearer .", "label": "", "metadata": {}, "score": "88.14661"}
{"text": "Other authors : no disclosure .References .Brink AJ , Feldman C , Richards GA , et al Emergence of extensive drug resistance ( XDR ) among Gram - negative bacilli in South Africa looms nearer .", "label": "", "metadata": {}, "score": "88.14661"}
{"text": "43 - 45 , 1984 .View at Google Scholar \u00b7 View at Scopus .I. Nathanson , G. J. A. Cropp , P. Li , and P. Neter , \" Effectiveness of aerosolized gentamicin in cystic fibrosis ( CF ) , \" Cystic Fibrosis Club Abstracts , vol .", "label": "", "metadata": {}, "score": "88.205894"}
{"text": "5 ] colistin seems to be very active in the initial killing of A. baumannii , even with 0.5 \u00d7 MIC , exhibiting a concentration - dependent bacterial - killing mechanism .", "label": "", "metadata": {}, "score": "88.253075"}
{"text": "J Antimicrob Chemother 2011 , 66 : 48 - 53 .10.1093/jac / dkq40821078604 View Article PubMed .Livermore DM , Mushtaq S : Activity of biapenem ( RPX2003 ) combined with the boronate beta - lactamase inhibitor RPX7009 against carbapenem - resistant Enterobacteriaceae .", "label": "", "metadata": {}, "score": "88.42003"}
{"text": "Carbapenems .Carbapenems have been used , though counter - intuitively , in the treatment of infections with CRE , usually as the adjuvant component of a combination drug regimen .", "label": "", "metadata": {}, "score": "88.43121"}
{"text": "Tigecycline has been shown to have in vitro activity against multidrug - resistant Enterobacteriaceae isolates [ 42 ] .Tigecycline has been used in the treatment of infections with CRE primarily as an adjuvant drug in combination therapy ( Table 3 ) [ 43 - 45 ] .", "label": "", "metadata": {}, "score": "88.584595"}
{"text": "This has the added benefit of further reducing treatment time , and does not require venting or filtering of exhaust gases .At present , the I - neb \u00ae is only available to those patients on Promixin \u00ae ( colistimethate sodium ) powder for nebulisation ( Profile Pharma ) which remains more expensive than colomycin .", "label": "", "metadata": {}, "score": "88.69129"}
{"text": "Rapid routine molecular detection of CRE is essential to optimise therapy and improve outcomes , and to limit the spread of such resistance through aggressive infection control , including the screening of high - risk patients and the facilitation of ' search and contain ' tactics .", "label": "", "metadata": {}, "score": "88.817795"}
{"text": "Rapid routine molecular detection of CRE is essential to optimise therapy and improve outcomes , and to limit the spread of such resistance through aggressive infection control , including the screening of high - risk patients and the facilitation of ' search and contain ' tactics .", "label": "", "metadata": {}, "score": "88.817795"}
{"text": "Rapid routine molecular detection of CRE is essential to optimise therapy and improve outcomes , and to limit the spread of such resistance through aggressive infection control , including the screening of high - risk patients and the facilitation of ' search and contain ' tactics .", "label": "", "metadata": {}, "score": "88.817795"}
{"text": "4 , pp .288 - 292 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Griese , I. M\u00fcller , and D. Reinhardt , \" Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis , \" European journal of medical research , vol .", "label": "", "metadata": {}, "score": "89.06448"}
{"text": "To recap : A resistance factor is spreading that leaves very serious infections treatable by only a single remaining drug , one which is acknowledged not to be perfect .", "label": "", "metadata": {}, "score": "89.06598"}
{"text": "One hundred and seventy - four references were discarded : 77 were not randomized / quasirandomized ( for an outcome with already existing RCTs ) , 38 on patients without CF , 21 substudies , 19 pharmacokinetic studies , 12 pharmacodynamic studies , 10 in vitro studies , and 7 pharmacoeconomic studies .", "label": "", "metadata": {}, "score": "89.23486"}
{"text": "10.1086/59241218973455 View Article PubMed .Snitkin ES , Zelazny AM , Thomas PJ , Stock F , Henderson DK , Palmore TN , Segre JA : Tracking a hospital outbreak of carbapenem - resistant Klebsiella pneumoniae with whole - genome sequencing .", "label": "", "metadata": {}, "score": "89.3759"}
{"text": "Transfer of patients who have been hospitalised in medical facilities or countries where endemicity of CRE isolates has been established is also a major risk factor .", "label": "", "metadata": {}, "score": "89.55611"}
{"text": "Transfer of patients who have been hospitalised in medical facilities or countries where endemicity of CRE isolates has been established is also a major risk factor .", "label": "", "metadata": {}, "score": "89.55611"}
{"text": "Transfer of patients who have been hospitalised in medical facilities or countries where endemicity of CRE isolates has been established is also a major risk factor .", "label": "", "metadata": {}, "score": "89.55611"}
{"text": "10.1128/AAC.00188 - 13371614523571536 View Article PubMed Central PubMed .Karaiskos I , Masgala A , Galani L , Baziaka F , Giamarellou H : Double carbapenems regimens for infections in humans due to carbapenemase - producing Klebsiella pneumonia ( CPKP ) .", "label": "", "metadata": {}, "score": "89.5802"}
{"text": "1250 - 1256 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Borer , L. Saidel - Odes , S. Eskira et al . , \" Risk factors for developing clinical infection with carbapenem - resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem - resistant K pneumoniae , \" The American Journal of Infection Control , vol .", "label": "", "metadata": {}, "score": "89.64769"}
{"text": "Eur Resp J 1998 ; 12:592 - 594 .[PubMed ] .Lee TWR , Brownlee KG , Denton M , et al .Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a Regional Pediatric Cystic Fibrosis Center .", "label": "", "metadata": {}, "score": "89.64791"}
{"text": "Antibiotic utilisation .Delaying the emergence of carbapenem resistance , particularly in areas of South Africa where resistance is still uncommon , can decrease the impact of CRE .", "label": "", "metadata": {}, "score": "89.78512"}
{"text": "Antibiotic utilisation .Delaying the emergence of carbapenem resistance , particularly in areas of South Africa where resistance is still uncommon , can decrease the impact of CRE .", "label": "", "metadata": {}, "score": "89.78512"}
{"text": "Antibiotic utilisation .Delaying the emergence of carbapenem resistance , particularly in areas of South Africa where resistance is still uncommon , can decrease the impact of CRE .", "label": "", "metadata": {}, "score": "89.78512"}
{"text": "10.1128/AAC.01402 - 10306712321173186 View Article PubMed Central PubMed .Prasad P , Sun J , Danner RL , Natanson C : Excess deaths associated with tigecycline after approval based on noninferiority trials .", "label": "", "metadata": {}, "score": "89.803444"}
{"text": "10.1111/j.1469 - 0691.2011.03514 .x21595793 View Article PubMed .Qureshi ZA , Paterson DL , Potoski BA , Kilayko MC , Sandovsky G , Sordillo E , Polsky B , Adams - Haduch JM , Doi Y : Treatment outcome of bacteremia due to KPC - producing Klebsiella pneumoniae : superiority of combination antimicrobial regimens .", "label": "", "metadata": {}, "score": "89.86059"}
{"text": "[Links ] .Best Care ...Always ![Links ] Indicadores .Links relacionados .Compartir .SAMJ , S. Afr . med .", "label": "", "metadata": {}, "score": "89.91859"}
{"text": "However , the mean time to the maximum fall in FEV 1 % predicted was significantly different between the solutions ( hypertonic 7.8 ( 2.1 ) min , isotonic 19.2 ( 5.5 ) min , and hypotonic 34.2 ( 5.9 ) min ) .", "label": "", "metadata": {}, "score": "89.91938"}
{"text": "12 , pp .1619 - 1629 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .O. Zarkotou , S. Pournaras , P. Tselioti et al . , \" Predictors of mortality in patients with bloodstream infections caused by KPC - producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment , \" Clinical Microbiology and Infection , vol .", "label": "", "metadata": {}, "score": "89.936325"}
{"text": "10.1128/AAC.01235 - 09279851819901089 View Article PubMed Central PubMed .Roussos N , Karageorgopoulos DE , Samonis G , Falagas ME : Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections .", "label": "", "metadata": {}, "score": "90.02053"}
{"text": "The odds ratio ( OR ) of P. aeruginosa positive culture comparing the cycled versus culture - based group was 0.78 ( 95 % CI , 0.49 - 1.23 ) and 1.10 ( 95 % CI , 0.71 - 1.71 ) comparing ciprofloxacin versus placebo .", "label": "", "metadata": {}, "score": "90.10453"}
{"text": "Identification and susceptibility testing of K. pneumoniae blood isolates were performed by the Vitek 2 automated system ( bioMerieux , Marcy l ' Etoile , France ) .", "label": "", "metadata": {}, "score": "90.17071"}
{"text": "847 - 856 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Taccetti , E. Bianchini , L. Cariani et al . , \" Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis : a randomised multicentre study comparing two different protocols , \" Thorax , vol .", "label": "", "metadata": {}, "score": "90.261635"}
{"text": "208 - 214 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . K. Halton , J. Zobell , M. MacKay , R. Ensign , and B. A. Chatfield , \" Evaluation of the effectiveness of a MRSA eradication protocol in pediatric CF patients , \" Pediatric Pulmonology , vol .", "label": "", "metadata": {}, "score": "90.27876"}
{"text": "[PubMed ] .Pitt TL , Sparrow M , Warner M , et al .Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents .", "label": "", "metadata": {}, "score": "90.28032"}
{"text": "[PubMed ] .Li J , Milne RW , Nation RL , et al .Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high performance liquid chromatography .", "label": "", "metadata": {}, "score": "90.407455"}
{"text": "Colistin is a multicomponent antibiotic with colistin A ( polymixin E1 ) and colistin B ( polymyxin E2 ) being the two major components ( Li et al , 2005 ) .", "label": "", "metadata": {}, "score": "90.487946"}
{"text": "Regarding the eradication protocol , there have been few uncontrolled studies done so far .These are summarized in Table 6 .Though the concerns about MRSA and the success with early P. aeruginosa eradication have encouraged several centers to attempt eradication of MRSA , the long - term results are unknown .", "label": "", "metadata": {}, "score": "90.738846"}
{"text": "Cystic fibrosis ( CF ) is the most frequent life - threatening congenital disease in Caucasians .Airway colonization with pathogens like P. aeruginosa and S. aureus belongs to the primary reasons for premature death in patients with CF and antibiotic treatment is a primary reason for improvement of life expectancy within the last decades in patients treated with aggressive antimicrobial regimes [ 1 ] .", "label": "", "metadata": {}, "score": "90.949875"}
{"text": "3026 - 3029 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .Z. Samra , O. Ofir , Y. Lishtzinsky , L. Madar - Shapiro , and J. Bishara , \" Outbreak of carbapenem - resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel , \" International Journal of Antimicrobial Agents , vol .", "label": "", "metadata": {}, "score": "91.00242"}
{"text": "11 , pp .1121 - 1134 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. E. Wainwright , A. L. Quittner , D. E. Geller et al . , \" Aztreonam for inhalation solution ( AZLI ) in patients with cystic fibrosis , mild lung impairment , and P. aeruginosa , \" Journal of Cystic fibrosis , vol .", "label": "", "metadata": {}, "score": "91.07921"}
{"text": "Abstract .The Acinetobacter baumannii - Acinetobacter calcoaceticus complex has become an important cause of traumatic wound infections in US Army soldiers injured in Iraq .", "label": "", "metadata": {}, "score": "91.20562"}
{"text": "CMS is excreted primarily in the urine ( as unchanged drug ) .No biliary excretion has been reported in humans .Data on the pharmacokinetics of i.v .", "label": "", "metadata": {}, "score": "91.28166"}
{"text": "10.1093/jac / dkt11823580564 View Article PubMed .Sutcliffe JA , O'Brien W , Fyfe C , Grossman TH : Antibacterial activity of eravacycline ( TP-434 ) , a novel fluorocycline , against hospital and community pathogens .", "label": "", "metadata": {}, "score": "91.4005"}
{"text": "Colistimethate sodium ( CMS ) is an inactive prodrug of colistin that exhibits a low level of protein binding .It is not stable in vitro and in vivo and is hydrolyzed in human plasma , creating a complex mixture of partially sulphomethylated derivatives with the potential to produce up to 32 different products , including colistin [ 1 ] .", "label": "", "metadata": {}, "score": "91.41601"}
{"text": "Specific antibiotics and specific antibiotic classes have frequently been implicated as risk factors for colonisation or infection with CRE , and these include all the carbapenems , cephalosporins , fluoroquinolones , aminoglycosides and \u03b2 - lactam / \u03b2 - lactamase inhibitors .", "label": "", "metadata": {}, "score": "91.434654"}
{"text": "Specific antibiotics and specific antibiotic classes have frequently been implicated as risk factors for colonisation or infection with CRE , and these include all the carbapenems , cephalosporins , fluoroquinolones , aminoglycosides and \u03b2 - lactam / \u03b2 - lactamase inhibitors .", "label": "", "metadata": {}, "score": "91.434654"}
{"text": "Specific antibiotics and specific antibiotic classes have frequently been implicated as risk factors for colonisation or infection with CRE , and these include all the carbapenems , cephalosporins , fluoroquinolones , aminoglycosides and \u03b2 - lactam / \u03b2 - lactamase inhibitors .", "label": "", "metadata": {}, "score": "91.434654"}
{"text": "10.1093/cid / cis270340471622467668 View Article PubMed Central PubMed .Tasina E , Haidich AB , Kokkali S , Arvanitidou M : Efficacy and safety of tigecycline for the treatment of infectious diseases : a meta - analysis .", "label": "", "metadata": {}, "score": "91.45264"}
{"text": "doi : 10.1093/cid / cir401 Abstract .Colistin is a rapidly bactericidal antimicrobial agent that possesses a significant postantibiotic effect against MDR Gram - negative pathogens , such as Pseudomonas aeruginosa , Acinetobacter baumannii , and Klebsiella pneumoniae .", "label": "", "metadata": {}, "score": "91.55241"}
{"text": "11 Unlike imipenem , colistin , and tigecycline , the other available agents often used to treat MDR - ABC , minocycline can be given orally .", "label": "", "metadata": {}, "score": "91.66588"}
{"text": "352160422914622 View Article PubMed Central PubMed .Evans HL , Lefrak SN , Lyman J , Smith RL , Chong TW , McElearney ST , Schulman AR , Hughes MG , Raymond DP , Pruett TL , Sawyer RG : Cost of Gram - negative resistance .", "label": "", "metadata": {}, "score": "91.7792"}
{"text": "The major risk factors for acquiring KPCs ( colonisation and/or infection ) are similar to those for extended - spectrum \u00e2 - lactamases ( ESBLs ) , the prevalence of which is extremely high in South Africa .", "label": "", "metadata": {}, "score": "91.79031"}
{"text": "The major risk factors for acquiring KPCs ( colonisation and/or infection ) are similar to those for extended - spectrum \u00e2 - lactamases ( ESBLs ) , the prevalence of which is extremely high in South Africa .", "label": "", "metadata": {}, "score": "91.79031"}
{"text": "The major risk factors for acquiring KPCs ( colonisation and/or infection ) are similar to those for extended - spectrum \u00e2 - lactamases ( ESBLs ) , the prevalence of which is extremely high in South Africa .", "label": "", "metadata": {}, "score": "91.79031"}
{"text": "Aztreonam Lysine ( AZLI , Inhaled ) versus Tobramycin ( Inhaled ) .Patients were randomized to three 28-day courses ( AZLI 75 mg TID or TNS 300 mg BD ) ; 28 off - days separated each course .", "label": "", "metadata": {}, "score": "91.837326"}
{"text": "Table 3 .Treatment regimens and outcomes of various infections with carbapenemase - producing organisms reported in the literature .CRE , carbapenem - resistant Enterobacteriaceae ; KPC , Klebsiella pneumoniae carbapenemase ; UTI , urinary tract infection ; VAP , ventilator - associated pneumonia .", "label": "", "metadata": {}, "score": "91.88231"}
{"text": "It seems as if minocycline meets these criteria rather well .In this report , we describe the successful treatment of MDR - ABC traumatic wound infections with minocycline .", "label": "", "metadata": {}, "score": "91.89928"}
{"text": "View at Google Scholar . E. Vanderhelst , E. De Wachter , J. Willekens , D. Pi\u00e9rard , W. Vincken , and A. Malfroot , \" Eradication of chronic methicillin - resistant Staphylococcus aureus infection in cystic fibrosis patients .", "label": "", "metadata": {}, "score": "91.91836"}
{"text": "Imipenem in combination with another novel beta - lactamase inhibitor , MK-7655 , appears active in vitro against serine carbapenemase - producing organisms and against P. aeruginosa , but not against metallo - carbapenemase - producing organisms or Acinetobacter baumannii [ 59 ] .", "label": "", "metadata": {}, "score": "92.00823"}
{"text": "Fosfomycin is another old broad - spectrum antibiotic that inhibits bacterial cell wall synthesis and has in vitro activity against CRE [ 12 , 55 ] .", "label": "", "metadata": {}, "score": "92.35185"}
{"text": "Objective .To identify risk factors for the first episode of Klebsiella Pneumonia resistant to carbapenems ( KPRC ) infection in critically ill patients .Design , Setting , and Methods .", "label": "", "metadata": {}, "score": "92.635475"}
{"text": "In a randomized trial including participants of 8 - 25 years of age , 21 were randomly assigned to oral ciprofloxacin alone and 23 were randomly assigned to ciprofloxacin plus inhaled amikacin [ 68 ] .", "label": "", "metadata": {}, "score": "92.701904"}
{"text": "This does not always occur in very young children and patients with poor lung function .A mouthpiece rather than a facemask should be used to maximise pulmonary deposition .", "label": "", "metadata": {}, "score": "92.725006"}
{"text": "Clin Infect Dis 2009 , 48 : 1724 - 1728 .10.1086/59922519438394 View Article PubMed .Bogdanovich T , Adams - Haduch JM , Tian GB , Nguyen MH , Kwak EJ , Muto CA , Doi Y : Colistin - resistant , Klebsiella pneumoniae carbapenemase ( KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258 .", "label": "", "metadata": {}, "score": "92.760155"}
{"text": "362 - 367 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Franklin , L. Liolios , and A. Y. Peleg , \" Phenotypic detection of carbapenem - susceptible metallo-", "label": "", "metadata": {}, "score": "92.79996"}
{"text": "KPRC was defined according to the revised Minimum Inhibitory Concentration ( MIC ) breakpoints as previously described [ 12 ] .KPRC infection was defined as clinical manifestation of infection which was microbiologically confirmed by isolation of KPRC in cultured material .", "label": "", "metadata": {}, "score": "93.08998"}
{"text": "2012 .FORUM ISSUES IN MEDICINE .The spread of carbapenem - resistant enterobacteriaceae in South Africa : risk factors for acquisition and prevention .Adrian Brink I ; Jennifer Coetzee II ; Cornelis Clay II ; Craig Corcoran II ; Johan van Greune III ; J D Deetlefs III ; Louise Nutt IV ; Charles Feldman V ; Guy Richards V ; Patrice Nordmann VI ; Laurent Poirel VI .", "label": "", "metadata": {}, "score": "93.115555"}
{"text": "12 , pp .1798 - 1803 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Tsakris , I. Kristo , A. Poulou et al . , \" Evaluation of boronic acid disk tests for differentiating KPC - possessing Klebsiella pneumoniae isolates in the clinical laboratory , \" Journal of Clinical Microbiology , vol .", "label": "", "metadata": {}, "score": "93.2548"}
{"text": "10.1086/59257718840079 View Article PubMed .Bergamasco MD , Barroso Barbosa M , de Oliveira Garcia D , Cipullo R , Moreira JC , Baia C , Barbosa V , Abboud CS : Infection with Klebsiella pneumoniae carbapenemase ( KPC)-producing K. pneumoniae in solid organ transplantation .", "label": "", "metadata": {}, "score": "93.27381"}
{"text": "Though the US Guidelines do not recommend use of prophylactic anti - staphylococcal antibiotics as the UK and Australian guidelines , however , recommend flucloxacillin prophylaxis starting from the infancy [ 82 ] .", "label": "", "metadata": {}, "score": "93.38396"}
{"text": "6 , pp .523 - 530 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Schelstraete , P. Deschaght , L. Van Simaey et al . , \" Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients , \" Journal of Cystic Fibrosis , vol .", "label": "", "metadata": {}, "score": "93.561935"}
{"text": "Cumulative antibiotic exposure is likely to be the most important factor determining risk for developing a CRE infection .It also appears that not only is prior cumulative antibiotic exposure a risk factor , but that the risk increases with increasing duration of treatment .", "label": "", "metadata": {}, "score": "93.66542"}
{"text": "Cumulative antibiotic exposure is likely to be the most important factor determining risk for developing a CRE infection .It also appears that not only is prior cumulative antibiotic exposure a risk factor , but that the risk increases with increasing duration of treatment .", "label": "", "metadata": {}, "score": "93.66542"}
{"text": "Cumulative antibiotic exposure is likely to be the most important factor determining risk for developing a CRE infection .It also appears that not only is prior cumulative antibiotic exposure a risk factor , but that the risk increases with increasing duration of treatment .", "label": "", "metadata": {}, "score": "93.66542"}
{"text": "Qualitative variables were compared using Chi - square test or Fisher 's exact test where appropriate ; quantitative variables were compared by one way ANOVA ( Bonferroni post hoc test ) .", "label": "", "metadata": {}, "score": "93.70338"}
{"text": "In a randomized crossover study 26 adult patients received ciprofloxacin 750 mg BID or ofloxacin 400 mg BID for 14 days , with three months washout period [ 69 ] .", "label": "", "metadata": {}, "score": "93.84433"}
{"text": "More studies , to include controlled trials , are needed to further determine the appropriate role of this agent in treating MDR - ABC .Talbot GH , Bradley J , Edwards JE , et al .", "label": "", "metadata": {}, "score": "93.87892"}
{"text": "[Links ] .Nordmann P , Naas T , Poirel L. Global spread of carbapenemase - producing Enterobacteriaceae .Emerg Infect Dis 2011;17:1791 - 1798 .", "label": "", "metadata": {}, "score": "94.16592"}
{"text": "[Links ] .Nordmann P , Naas T , Poirel L. Global spread of carbapenemase - producing Enterobacteriaceae .Emerg Infect Dis 2011;17:1791 - 1798 .", "label": "", "metadata": {}, "score": "94.16592"}
{"text": "[Links ] .Nordmann P , Naas T , Poirel L. Global spread of carbapenemase - producing Enterobacteriaceae .Emerg Infect Dis 2011;17:1791 - 1798 .", "label": "", "metadata": {}, "score": "94.16592"}
{"text": "CCM.0000251496.61520.7517110877 View Article PubMed .Queenan AM , Bush K : Carbapenemases : the versatile beta - lactamases .Clin Microbiol Rev 2007 , 20 : 440 - 458 .", "label": "", "metadata": {}, "score": "94.30121"}
{"text": "Staphylococcus aureus .S. aureus is one of the first microbes and also one of the commonest to infect patients with cystic fibrosis .There has been an increase in the prevalence of colonization / infection with both methicillin - susceptible ( MSSA ) and methicillin resistant ( MRSA ) S. aureus over the past decade [ 73 ] .", "label": "", "metadata": {}, "score": "94.518974"}
{"text": "FORUM ISSUES IN MEDICINE .The spread of carbapenem - resistant enterobacteriaceae in South Africa : risk factors for acquisition and prevention .Adrian Brink I ; Jennifer Coetzee II ; Cornelis Clay II ; Craig Corcoran II ; Johan van Greune III ; J D Deetlefs III ; Louise Nutt IV ; Charles Feldman V ; Guy Richards V ; Patrice Nordmann VI ; Laurent Poirel VI .", "label": "", "metadata": {}, "score": "94.564064"}
{"text": "The Ventstream and Pari LC Plus , which are used for antibiotics , direct the patient 's inspiratory flow through the nebuliser chamber , thereby increasing the effective inhaled nebuliser output .", "label": "", "metadata": {}, "score": "94.65723"}
{"text": "12 , pp .1430 - 1435 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. S. Garner , W. R. Jarvis , T. G. Emori , T. C. Horan , and J. M. Hughes , \" CDC Defionitions for nosocomial infections , 1988 , \" The American Journal of Infection Control , vol .", "label": "", "metadata": {}, "score": "94.70874"}
{"text": "Cite : Bogdanovich T. et al .Colistin - Resistant , Klebsiella pneumoniae Carbapenemase ( KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258 .", "label": "", "metadata": {}, "score": "94.85597"}
{"text": "45 - 52 , 1990 .View at Google Scholar \u00b7 View at Scopus .G. Doring and N. Hoiby , \" Early intervention and prevention of lung disease in cystic fibrosis : a European consensus , \" Journal of Cystic fibrosis , vol .", "label": "", "metadata": {}, "score": "94.86293"}
{"text": "Clin Infect Dis 2011;53:60 - 67 .Brink AJ , Coetzee J , Clay C , et al .Emergence of New Delhi metallo - beta - lactamase ( NDM-1 ) and Klebsiella pneumoniae carbapenemase ( KPC-2 ) in South Africa .", "label": "", "metadata": {}, "score": "94.97457"}
{"text": "Clin Infect Dis 2011;53:60 - 67 .Brink AJ , Coetzee J , Clay C , et al .Emergence of New Delhi metallo - beta - lactamase ( NDM-1 ) and Klebsiella pneumoniae carbapenemase ( KPC-2 ) in South Africa .", "label": "", "metadata": {}, "score": "94.97457"}
{"text": "Clin Infect Dis 2011;53:60 - 67 .Brink AJ , Coetzee J , Clay C , et al .Emergence of New Delhi metallo - beta - lactamase ( NDM-1 ) and Klebsiella pneumoniae carbapenemase ( KPC-2 ) in South Africa .", "label": "", "metadata": {}, "score": "94.97457"}
{"text": "Eur J Pharm Biopharm 2002 ; 54:25 - 32 .[PubMed ] .Ledson MJ , Gallagher MJ , Cowperthwaite C , et al .", "label": "", "metadata": {}, "score": "95.07281"}
{"text": "A concerted global commitment to the intelligent use of antimicrobials , better antibiotic stewardship , the implementation of effective infection control strategies , and the development of more effective therapies are desperately needed .", "label": "", "metadata": {}, "score": "95.27852"}
{"text": "First , the antibiotic strategy about eradication of first or new airway colonization and treatment of chronically persistent airway colonization with P. aeruginosa will be discussed followed by the strategy for chronic suppressive therapy and eradication of S. aureus ( both MSSA and MRSA ) .", "label": "", "metadata": {}, "score": "95.47277"}
{"text": "While ASPs were initiated at pilot hospitals in South Africa , outpatient antibiotic use in this country has not been addressed and it is now crucial also to target general practitioners and the South African public as a whole .", "label": "", "metadata": {}, "score": "95.562164"}
{"text": "While ASPs were initiated at pilot hospitals in South Africa , outpatient antibiotic use in this country has not been addressed and it is now crucial also to target general practitioners and the South African public as a whole .", "label": "", "metadata": {}, "score": "95.562164"}
{"text": "While ASPs were initiated at pilot hospitals in South Africa , outpatient antibiotic use in this country has not been addressed and it is now crucial also to target general practitioners and the South African public as a whole .", "label": "", "metadata": {}, "score": "95.562164"}
{"text": "Colistin ( polymyxin E ) is an old bactericidal antibiotic with cationic detergent properties .It disrupts the outer cell membrane of the Gram - negative bacilli by binding to the lipid A component of the lipopolysaccharide , causing leakage of cytoplasmic contents and bacterial cell death [ 13 ] .", "label": "", "metadata": {}, "score": "95.647705"}
{"text": "Hand searching of the bibliography of relevant citations yielded an additional 32 papers that were retrieved and examined .Results .After applying above exclusion criteria ( under study selection ) , removing the duplicates , and excluding review papers , 208 references were obtained .", "label": "", "metadata": {}, "score": "95.64879"}
{"text": "e122-e126 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. B. Gasink , P. H. Edelstein , E. Lautenbach , M. Synnestvedt , and N. O. Fishman , \" Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase - producing K. pneumoniae , \" Infection Control and Hospital Epidemiology , vol .", "label": "", "metadata": {}, "score": "95.68672"}
{"text": "The multidrug - resistant Acinetobacter baumannii - Acinetobactercal coaceticus complex ( MDR - ABC ) is a problematic cause of nosocomial infection worldwide . 1 The organism 's ability to easily acquire antimicrobial resistance , combined with a lack of further drug development , has led to an ever - shrinking armamentarium of effective antimicrobials . 2", "label": "", "metadata": {}, "score": "95.74367"}
{"text": "Following parenteral administration of sodium colistin methanesulphate , the principal route of excretion is via the kidneys ( 65 - 75 % ) .Sodium colistin methanesulphate is further hydrolysed to colistin following parenteral administration with a half - life of 82 - 268 min and 139 - 385 min respectively ( Li et al , 2003 ) .", "label": "", "metadata": {}, "score": "95.89284"}
{"text": "Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis .J Clin Microbiol 2009 , 47 : 1613 .10.1128/JCM.00404 - 09268188219403778 View Article PubMed Central PubMed .", "label": "", "metadata": {}, "score": "96.245026"}
{"text": "Daniel Peckham , Jim Littlewood , Steve Conway , Kim Pollard and Tracey Hughes .April , 2008 .The use of Colistin in Cystic Fibrosis [ online].", "label": "", "metadata": {}, "score": "96.30231"}
{"text": "B .First isolated in Sweden from a traveler previously hospitalized in New Delhi ; large environmental reservoirs in India , Pakistan , Middle East , and the Balkans [ 8 ] ; recent ERCP - related nosocomial outbreak associated with infected endoscopes reported in Chicago , IL [ 9 ] .", "label": "", "metadata": {}, "score": "96.532196"}
{"text": "10.1093/jac / dki17515917285 View Article PubMed .Nordmann P , Naas T , Poirel L : Global spread of Carbapenemase - producing Enterobacteriaceae .", "label": "", "metadata": {}, "score": "96.562"}
{"text": "4 , pp .1035 - 1041 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. W. Waterer and R. G. Wunderink , \" Increasing threat of Gram - negative bacteria , \" Critical Care Medicine , vol .", "label": "", "metadata": {}, "score": "96.77654"}
{"text": "Whilst acquisition of P. aeruginosa may occur quite early in life , the transition from the non - mucoid to the mucoid phenotype may take several years .", "label": "", "metadata": {}, "score": "96.91501"}
{"text": "4 , pp .626 - 630 , 1982 .View at Google Scholar \u00b7 View at Scopus .F. Ratjen , G. Comes , K. Paul , H. G. Posselt , T. O. Wagner , and K. Harms , \" German Board of the European Registry for Cystic fibrosis ( ERCF ) .", "label": "", "metadata": {}, "score": "97.14072"}
{"text": "MATERIALS AND METHODS .This study was a retrospective chart review of patients cared for at Brooke Army Medical Center in Fort Sam Houston , Texas , during 2005 and 2006 .", "label": "", "metadata": {}, "score": "97.43175"}
{"text": "10.1007/s15010 - 011 - 0161 - 121789524 View Article PubMed .Lee GC , Burgess DS : Treatment of Klebsiella pneumoniae carbapenemase ( KPC ) infections : a review of published case series and case reports .", "label": "", "metadata": {}, "score": "97.52157"}
{"text": "Address correspondence and reprint requests to Clinton K. Murray , MD , MAJ(P ) , MC , USA , Infectious Disease Service , MCHE - MDI , Brooke Army Medical Center , 3851 Roger Brooke Dr , Fort Sam Houston , TX 78234 .", "label": "", "metadata": {}, "score": "97.619"}
{"text": "Conclusions .None of the antimicrobials currently in development has activity against the entire spectrum of carbapenemase - producing Gram - negative bacteria .The mortality associated with the failure rates from the current salvage therapies highlighted above is disconcerting .", "label": "", "metadata": {}, "score": "97.705414"}
{"text": "Subsequently , carbapenem - resistant Enterobacteriaceae ( CRE ) have indeed become our ' worst nightmare ' , locally and internationally , and pose a major threat to the viability of all currently available antibiotics .", "label": "", "metadata": {}, "score": "97.71325"}
{"text": "Subsequently , carbapenem - resistant Enterobacteriaceae ( CRE ) have indeed become our ' worst nightmare ' , locally and internationally , and pose a major threat to the viability of all currently available antibiotics .", "label": "", "metadata": {}, "score": "97.71325"}
{"text": "Subsequently , carbapenem - resistant Enterobacteriaceae ( CRE ) have indeed become our ' worst nightmare ' , locally and internationally , and pose a major threat to the viability of all currently available antibiotics .", "label": "", "metadata": {}, "score": "97.71325"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' Affiliations .References .Clin Microbiol Infect 2012 , 18 : 268 - 281 .", "label": "", "metadata": {}, "score": "97.86261"}
{"text": "6 , pp .525 - 529 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Bratu , M. Mooty , S. Nichani et al . , \" Emergence of KPC - possessing Klebsiella pneumoniae in Brooklyn , New York : epidemiology and recommendations for detection , \" Antimicrobial Agents and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "98.05377"}
{"text": "We will discuss below the treatment ( prophylactic and eradication ) strategy for S. aureus .Methicillin Sensitive S. aureus ( MSSA ) .The approach for eradication of an initial infection and chronic suppressive treatment are different .", "label": "", "metadata": {}, "score": "98.37679"}
{"text": "A preliminary study .Clin Infect Dis 2012 , 54 : 1720 - 1726 .10.1093/cid / cis286335748022423120 View Article PubMed Central PubMed .", "label": "", "metadata": {}, "score": "98.923996"}
{"text": "The carbapenemases belong to different classes and include : . 4 As depicted in Fig .1 , the emergence of the broad - spectrum antibiotic - inactivating enzyme , OXA-48 , and its derivatives among Enterobacteriaceae from hospitalised patients in Johannesburg , Cape Town and Port Elizabeth has been confirmed ( unpublished , J Coetzee , February 2012 ) .", "label": "", "metadata": {}, "score": "98.96713"}
{"text": "The carbapenemases belong to different classes and include : . 4 As depicted in Fig .1 , the emergence of the broad - spectrum antibiotic - inactivating enzyme , OXA-48 , and its derivatives among Enterobacteriaceae from hospitalised patients in Johannesburg , Cape Town and Port Elizabeth has been confirmed ( unpublished , J Coetzee , February 2012 ) .", "label": "", "metadata": {}, "score": "98.96713"}
{"text": "The carbapenemases belong to different classes and include : . 4 As depicted in Fig .1 , the emergence of the broad - spectrum antibiotic - inactivating enzyme , OXA-48 , and its derivatives among Enterobacteriaceae from hospitalised patients in Johannesburg , Cape Town and Port Elizabeth has been confirmed ( unpublished , J Coetzee , February 2012 ) .", "label": "", "metadata": {}, "score": "98.96713"}
{"text": "Colistimethate sodium causes less pain upon injection than the base or sulphate and appears to have a superior therapeutic ratio to the sulphate .Colistin sulphate is used orally and topically while sodium colistin methanesulphate is used by injection and inhalation .", "label": "", "metadata": {}, "score": "99.223206"}
{"text": "A Cochrane Library ( CENTRAL ) search using the term \" antibiotics \" and filter \" Record Title \" yielded 26 Cochrane Systematic Reviews ( CSR ) and 1 protocol , 15 other ( systematic ) reviews , and 124 clinical trials .", "label": "", "metadata": {}, "score": "99.684525"}
{"text": "In our prospective study , despite that the groups of patients were comparable in terms of age , burden of disease ( APACHE ) , and cause of admission , the number of outcomes was small to draw definitive conclusions .", "label": "", "metadata": {}, "score": "99.696106"}
{"text": "Characteristics associated with carbapenemase - producing organisms commonly encountered in clinical practice .First isolated in US in 1996 ; now endemic in US , Colombia , Brazil , Argentina , Poland , Italy , Greece , Israel , and China [ 6 ] .", "label": "", "metadata": {}, "score": "99.93407"}
{"text": "10.1111/1469 - 0691.1234123992130 View Article PubMed .Cai Y , Wang R , Liang B , Bai N , Liu Y : Systematic review and meta - analysis of the effectiveness and safety of tigecycline for treatment of infectious disease .", "label": "", "metadata": {}, "score": "100.630356"}
{"text": "10 , pp .853 - 859 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Littlewood , M. G. Miller , A. T. Ghoneim , and C. H. Ramsden , \" Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "100.65992"}
{"text": "10.3201/eid1710.110655331068222000347 View Article PubMed Central PubMed .Centers for Disease Control and Prevention ( CDC ) : Notes from the Field : New Delhi metallo - \u03b2 - lactamase - producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois , 2013 .", "label": "", "metadata": {}, "score": "100.760025"}
{"text": "Lancet Infect Dis 2013 , 13 : 785 - 796 .10.1016/S1473 - 3099(13)70190 - 723969216 View Article PubMed .Bratu S , Tolaney P , Karumudi U , Quale J , Mooty M , Nichani S , Landman D : Carbapenemase - producing Klebsiella pneumoniae in Brooklyn , NY : molecular epidemiology and in vitro activity of polymyxin B and other agents .", "label": "", "metadata": {}, "score": "100.951935"}
{"text": "Conflict of interests declaration .No external funding was received for the molecular work at the Ampath Molecular Laboratory .AB has received recent research funding from Merck and Sanofi - Aventis , and has served on the advisory board of MSD , Aspen and Pfizer and on speakers ' bureau for GlaxoSmithKline ( GSK ) , Merck , Pfizer and Sanofi - Aventis .", "label": "", "metadata": {}, "score": "101.11978"}
{"text": "Conflict of interests declaration .No external funding was received for the molecular work at the Ampath Molecular Laboratory .AB has received recent research funding from Merck and Sanofi - Aventis , and has served on the advisory board of MSD , Aspen and Pfizer and on speakers ' bureau for GlaxoSmithKline ( GSK ) , Merck , Pfizer and Sanofi - Aventis .", "label": "", "metadata": {}, "score": "101.11978"}
{"text": "Conflict of interests declaration .No external funding was received for the molecular work at the Ampath Molecular Laboratory .AB has received recent research funding from Merck and Sanofi - Aventis , and has served on the advisory board of MSD , Aspen and Pfizer and on speakers ' bureau for GlaxoSmithKline ( GSK ) , Merck , Pfizer and Sanofi - Aventis .", "label": "", "metadata": {}, "score": "101.11978"}
{"text": "To prevent deaths from untreatable Gram - negative infections in South Africa , the rights of any doctor , whether in general or in hospital practice , to indiscriminately prescribe whatever antibiotic they wish , and in whatever fashion , must be challenged .", "label": "", "metadata": {}, "score": "101.13837"}
{"text": "To prevent deaths from untreatable Gram - negative infections in South Africa , the rights of any doctor , whether in general or in hospital practice , to indiscriminately prescribe whatever antibiotic they wish , and in whatever fashion , must be challenged .", "label": "", "metadata": {}, "score": "101.13837"}
{"text": "To prevent deaths from untreatable Gram - negative infections in South Africa , the rights of any doctor , whether in general or in hospital practice , to indiscriminately prescribe whatever antibiotic they wish , and in whatever fashion , must be challenged .", "label": "", "metadata": {}, "score": "101.13837"}
{"text": "Blood counts and biochemical measurements were performed daily .Statistical Analysis .Results are presented as frequency ( % ) for qualitative variables or median ( 25th and 75th quartiles ) for quantitative variables .", "label": "", "metadata": {}, "score": "101.37448"}
{"text": "10.1111/j.1469 - 0691.2009.02921 . x19694767View Article PubMed .Int J Antimicrob Agents 2014 , 43 : 52 - 59 .10.1016/j.ijantimicag.2013.09.01024183799 View Article PubMed .", "label": "", "metadata": {}, "score": "101.57358"}
{"text": "Search Strategy .We searched the Cochrane Central Register of Controlled Trials ( CENTRAL ) , which contains the Cochrane Cystic Fibrosis Group and the Cochrane Infectious Diseases Group Specialized Registers , MEDLINE ( 1970 to June 2013 ) .", "label": "", "metadata": {}, "score": "101.877495"}
{"text": "10.1128/AAC.01733 - 10312244021555763 View Article PubMed Central PubMed .Antimicrob Agents Chemother 2009 , 53 : 3430 - 3436 .10.1128/AAC.01361 - 08271559919433570 View Article PubMed Central PubMed .", "label": "", "metadata": {}, "score": "102.12233"}
{"text": "GAR has served on the speaker 's bureau of and/or received funding for congress travel from Sanofi - Aventis , Pfizer , Merck and Co. and Bristol - Myers Squibb , Astra - Zeneca , Roche , Winthrop , Aspen , Bayer , GSK , Janssen , Fresenius Kabi and Abbott .", "label": "", "metadata": {}, "score": "102.341385"}
{"text": "GAR has served on the speaker 's bureau of and/or received funding for congress travel from Sanofi - Aventis , Pfizer , Merck and Co. and Bristol - Myers Squibb , Astra - Zeneca , Roche , Winthrop , Aspen , Bayer , GSK , Janssen , Fresenius Kabi and Abbott .", "label": "", "metadata": {}, "score": "102.341385"}
{"text": "GAR has served on the speaker 's bureau of and/or received funding for congress travel from Sanofi - Aventis , Pfizer , Merck and Co. and Bristol - Myers Squibb , Astra - Zeneca , Roche , Winthrop , Aspen , Bayer , GSK , Janssen , Fresenius Kabi and Abbott .", "label": "", "metadata": {}, "score": "102.341385"}
{"text": "\u00a9 Michalopoulos and Falagas ; licensee Springer .This article is published under license to BioMed Central Ltd.Treatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis .", "label": "", "metadata": {}, "score": "103.25645"}
{"text": "10.1093/jac / dks27022782489 View Article PubMed .Clin Infect Dis 2013 , 56 : 1685 - 1694 .370742623599308 View Article PubMed Central PubMed .", "label": "", "metadata": {}, "score": "104.749374"}
{"text": "Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients : A Prospective Study .Department of Critical Care , School of Medicine , University of Thessaly , University Hospital of Larissa , 41110 Thessaly , Greece .", "label": "", "metadata": {}, "score": "105.231125"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. E. Hodson , A. R. L. Penketh , and J. C. Batten , \" Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "105.62014"}
{"text": "Review .Introduction .The global spread of carbapenem - resistant Enterobacteriaceae ( CRE ) has become a major challenge in clinical and public health settings .", "label": "", "metadata": {}, "score": "105.783066"}
{"text": "Introduction .Colistin is an antibacterial cationic cyclic polypeptide belonging to the group of antibiotics called the polymyxins .It is produced as a secondary metabolite from the spore - forming Bacillus polymyxa var colistinus .", "label": "", "metadata": {}, "score": "106.149216"}
{"text": "Affiliated with .Abstract .The global spread of carbapenem - resistant Enterobacteriaceae ( CRE ) is increasingly becoming a major challenge in clinical and public health settings .", "label": "", "metadata": {}, "score": "106.465195"}
{"text": "Indicators .Related links .Share .SAMJ , S. Afr . med .j. vol.102 n.7 Cape Town Jul. 2012 .FORUM ISSUES IN MEDICINE .", "label": "", "metadata": {}, "score": "107.00883"}
{"text": "It has completed phase 2 trials [ 60 ] .Eravacycline is a novel tetracycline that is not susceptible to efflux resistance mechanisms or to the protection of the ribosomal target that renders older tetracyclines ineffective .", "label": "", "metadata": {}, "score": "107.27446"}
{"text": "Most CRE have beta - lactamases belonging to the Ambler class A , B , and D [ 5 ] .Table 1 summarizes main examples from each class of carbapenemase - producing organisms .", "label": "", "metadata": {}, "score": "107.72618"}
{"text": "Carbapenemases .Carbapenem resistance among Enterobacteriaceae can be conferred by several genetic mechanisms , but epidemiologically the most important of them results in the production of beta - lactamases ( carbapenemases ) , which hydrolyse carbapenems and most other beta - lactams .", "label": "", "metadata": {}, "score": "108.36573"}
{"text": "Carbapenemases .Carbapenem resistance among Enterobacteriaceae can be conferred by several genetic mechanisms , but epidemiologically the most important of them results in the production of beta - lactamases ( carbapenemases ) , which hydrolyse carbapenems and most other beta - lactams .", "label": "", "metadata": {}, "score": "108.36573"}
{"text": "Carbapenemases .Carbapenem resistance among Enterobacteriaceae can be conferred by several genetic mechanisms , but epidemiologically the most important of them results in the production of beta - lactamases ( carbapenemases ) , which hydrolyse carbapenems and most other beta - lactams .", "label": "", "metadata": {}, "score": "108.36573"}
{"text": "10.1016/j.ijantimicag.2009.10.00520006471 View Article PubMed .Clin Infect Dis 2013 , 57 : 524 - 531 .10.1093/cid / cit33423697744 View Article PubMed .", "label": "", "metadata": {}, "score": "108.806656"}
{"text": "Competing interests .Argyris Michalopoulos declares that he has no competing interests .Mathew E. Falagas has participated in advisory boards of Pfizer , Astellas , and Bayer and has received lecture honoraria from Merck , Pfizer , AstraZeneca , Astellas , Cipla , Novartis , and Glenmark .", "label": "", "metadata": {}, "score": "111.41735"}
{"text": "10.1111/j.1469 - 0691.2011.03553 .x21635663 View Article PubMed .J Chemother 2013 , 25 : 129 - 140 .10.1179/1973947812Y.000000006223783137 View Article PubMed .", "label": "", "metadata": {}, "score": "112.28399"}
{"text": "10.1016/S1473 - 3099(11)70177 - 321784708 View Article PubMed .Diagn Microbiol Infect Dis 2010 , 68 : 140 - 151 .10.1016/j.diagmicrobio.2010.05.01220846586 View Article PubMed .", "label": "", "metadata": {}, "score": "112.54757"}
{"text": "10.1128/AAC.06268 - 11331835022252816 View Article PubMed Central PubMed .Clin Infect Dis 2012 , 55 : 943 - 950 .10.1093/cid / cis58822752516 View Article PubMed .", "label": "", "metadata": {}, "score": "112.92974"}
{"text": "D .OXA-48 .K. pneumoniae .First identified in Turkey in 2003 ; multiple nosocomial outbreaks reported since then throughout the world [ 7 ] .", "label": "", "metadata": {}, "score": "113.60533"}
{"text": "Alfa Institute of Biomedical Sciences ( AIBS ) .Department of Medicine , Henry Dunant Hospital .Department of Medicine , Tufts University School of Medicine .", "label": "", "metadata": {}, "score": "113.93621"}
{"text": "The Best Care ... Always !( BCA ) campaign was initiated in 2009 to support southern African healthcare organisations in implementing specific , internationally recognised , evidence - based interventions that enhance patient safety and constitute current best practice in hospital care .", "label": "", "metadata": {}, "score": "114.40962"}
{"text": "The Best Care ... Always !( BCA ) campaign was initiated in 2009 to support southern African healthcare organisations in implementing specific , internationally recognised , evidence - based interventions that enhance patient safety and constitute current best practice in hospital care .", "label": "", "metadata": {}, "score": "114.40962"}
{"text": "The Best Care ... Always !( BCA ) campaign was initiated in 2009 to support southern African healthcare organisations in implementing specific , internationally recognised , evidence - based interventions that enhance patient safety and constitute current best practice in hospital care .", "label": "", "metadata": {}, "score": "114.40962"}
{"text": "68 , no .4 , pp .344 - 350 , 2013 .View at Google Scholar .183 , no .11 , pp .", "label": "", "metadata": {}, "score": "115.067116"}
{"text": "History of colistin .Colistin was first discovered by Koyama et al in 1949 , as a fermentation product of the bacteria , Bacillus colistinus ( Koyama et al , 1950 ) .", "label": "", "metadata": {}, "score": "115.47554"}
{"text": "171 - 178 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Schuster , C. Haliburn , G. D\u00f6ring , and M. H. Goldman , \" Freedom Study Group .", "label": "", "metadata": {}, "score": "118.98257"}
{"text": "[Links ] .Best Care ...Always ![Links ] Wolters Kluwer Health may email you for journal alerts and information , but is committed to maintaining your privacy and will not share your personal information without your express consent .", "label": "", "metadata": {}, "score": "120.26757"}
{"text": "44 , no . 9 , pp .3139 - 3144 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "121.25904"}
{"text": "10.1093/jac / dkq226 PubMed Central PubMed View Article .Clin Ther 2008 , 30 : 143 - 151 .10.1016/j.clinthera.2008.01.015 PubMed View Article .", "label": "", "metadata": {}, "score": "121.951645"}
{"text": "[ Pari LC Plus with Pari Turbo Boy compressor Vs .Pari LC Star with \" intelligent compressor Akita .- the latter more efficient drug delivery ] .", "label": "", "metadata": {}, "score": "122.01517"}
{"text": "60 , no .5 , pp .1124 - 1130 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "123.09833"}
{"text": "12 , pp .1180 - 1185 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .31 , no .", "label": "", "metadata": {}, "score": "123.48836"}
{"text": "666 - 671 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .66 , no .6 , Article ID dkr116 , pp .", "label": "", "metadata": {}, "score": "124.22339"}
{"text": "4 , Article ID dkq005 , pp .784 - 788 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "125.588806"}
{"text": "Adrian Brink I ; Jennifer Coetzee II ; Cornelis Clay II ; Craig Corcoran II ; Johan van Greune III ; J D Deetlefs III ; Louise Nutt IV ; Charles Feldman V ; Guy Richards V ; Patrice Nordmann VI ; Laurent Poirel VI .", "label": "", "metadata": {}, "score": "127.25667"}
{"text": "10.1128/AAC.01288 - 13381127723979750 View Article PubMed Central PubMed .Copyright .\u00a9The Author(s ) 2014 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "133.32184"}
{"text": "113 - 119 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus", "label": "", "metadata": {}, "score": "133.79182"}
{"text": "Academic Editors : A. Sihoe and F. Varoli .Copyright \u00a9 2013 Rashmi Ranjan Das et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "143.99373"}
{"text": "Academic Editor : Saad Nseir .Copyright \u00a9 2013 Konstantinos Mantzarlis et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "147.34735"}
